Sitemap

Prediction of Metastases to Cervical Lymph Nodes from Squamous Cell Carcinoma of the Tongue and Floor of the Mouth Based on the Histologic Malignancy Score and Vascular Invasion

Risk Factors for Malignant Neoplasm in the Adult Tonsil

Histopathologic Malignancy Score of Jakobsson et al in Squamous Cell Carcinoma of the Head and Neck

TNM Staging for Cancers of the Lip and Oral Cavity

T and N Integer Score (TANIS) Staging System for Squamous Cell Carcinoma of the Oral Cavity

Functional Severity Index and Extended Clinical Severity Staging System for Cancer of the Tongue or Floor of the Mouth

Risk Factors for Squamous Cell Carcinoma of the Lip

Risk Factors for Lymph Node Metastasis in Patients with Squamous Cell Carcinoma of the Lip

M.D. Anderson Risk Scores for Head and Neck Cancer Recurrence at the Primary Site and in the Neck

M.D. Anderson Risk Factors for Recurrence in Patients with Cancer of the Head and Neck

Predictors of Medow et al for Patients with Squamous Cell Carcinoma of the Head and Neck

TNM Staging for Cancers of the Hypopharynx

TNM Staging for Cancers of the Oropharynx

Pretreatment Probability Model of van den Broek et al for 2 Year Survival After Intra-arterial Chemoradiation in a Patient with Advanced Head and Neck Carcinoma

Pretreatment Probability Model of van den Broek et al for 2 Year Local Control After Intra-arterial Chemoradiation in a Patient with Advanced Head and Neck Carcinoma

Prognostic Factors of Argiris et al for a Patient with Recurrent or Metastatic Carcinoma of the Head and Neck

Histologic Features of Saywell and Weedon in Squamous Cell Carcinoma of the Lip Associated with Metastatic Disease

DIAGS Index of Mori et al for Predicting Lymph Node Metastases in a Patient with a Squamous Cell Carcinoma of the Oral Cavity

The Clinical Severity Staging System of Pugliano et al for Carcinoma of the Oral Cavity

Immunohistochemical Patterns of Zarovnaya and Black Distinguishing Pseudoepitheliomatous Hyperplasia (PEH) from Squamous Cell Carcinoma (SCC)

Prognostic Indicators of Le Tourneau et al for Survival in a Patient with a Squamous Cell Carcinoma of the Head and Neck

Grades of Ojiri et al for CT Scan Documented Response to Therapy of an Oropharyngeal Squamous Cell Carcinoma

Risk Factors of Garavello et al for Distant Metastases in a Patient with Squamous Cell Carcinoma of the Head and Neck

Risk Factors of Liao et al for Distant Metastases in a Patient with Squamous Cell Carcinoma of the Oral Cavity

Nomogram of Tanvetyanon et al for Predicting Survival in a Patient Undergoing Reirradiation for a Head and Neck Cancer Arising in a Previously Irradiated Site

Basaloid Squamous Cell Carcinoma of the Head and Neck

Model of van den Broek et al for Predicting Local Control of an Advanced Head and Neck Squamous Cell Carcinoma Treated with Intra-Arterial Chemoradiation

Model of van den Broek et al for Predicting 2 Year Overall Survival for a Patient with an Advanced Head and Neck Squamous Cell Carcinoma Treated with Intra-Arterial Chemoradiation

Classification Scheme of Ho for Nasopharyngeal Carcinoma

Prognostic Factors of Heng et al for Nondisseminated Nasopharyngeal Carcinoma

Model of Waldron and Witterick for Predicting Survival in a Patient with Paranasal Sinus Cancer Based on the Clinical Extent of the Primary Tumor

Istituto Nazionale per lo Studio e la Cura dei Tumori (INT) Classification of Malignant Ethmoid Tumors

TNM Staging for Cancer of the Maxillary Sinus

TNM Staging for Cancer of the Nasopharynx

TNM Staging for Cancer of the Nasal Cavity and Ethmoid Sinus

Prognostic Model of Leung et al for a Patient with Nasopharyngeal Carcinoma Based on Plasma EBV DNA Load and TNM Stage

Score of Grandi et al for Staging a Patient with Nasopharyngeal Cancer

Modified Kadish Staging System for Esthesioneuroblastoma (Olfactory Neuroblastoma)

Prognostic Scores of Neel et al for a Patient with Nasopharyngeal Carcinoma (NPC)

Histologic Grading Criteria of Hyams for Esthesioneuroblastoma (Olfactory Neuroblastoma)

Prognostic Index Score of Ong et al for Metastatic Nasopharyngeal Carcinoma

TNM Classification and Staging of Salivary Gland Tumors

Prognostic Scores of Vander Poorten et al for Patients with Parotid Carcinoma

Revised TNM Classification and Staging of Salivary Gland Tumors

Grading Criteria of Goode et al for Mucoepidemoid Carcinoma of Salivary Glands (AFIP Criteria)

Grading Criteria of Brandwein et al for Mucoepidermoid Carcinoma of Salivary Glands (Modified AFIP Criteria)

Grading Criteria of Healey et al for Mucoepidermoid Carcinoma of Salivary Gland Origin

Risk Factors of de Brito Santos for Cervical Lymph Node Metastases in a Patient with a Parotid Carcinoma

Risk Factors of Sung et al Associated with Metastastic Adenoid Cystic Carcinoma Arising in the Head or Neck

Model of Carrillo et al for Predicting Recurrence of a Parotid Carcinoma

Histologic Grades of Szanto et al for Adenoid Cystic Carcinoma of a Salivary Gland

Histologic Features of Adenoid Cystic Carcinoma with High Grade Transformation (Dedifferentiation)

Histologic Features of Gomez et al Impacting Prognosis for a Patient with an Acinic Cell Carcinoma of the Parotid Gland

Use of Stage and p63 Immunostaining to Predict Prognosis for a Patient with an Adenoid Cystic Carcinoma Arising in a Salivary Gland

Risk Factors of Bhayani et al for Distant Metastases in a Patient with Clinical Stage I or II Adenoid Cystic Carcinoma Arising in a Major Salivary Gland

Prognostic Factors in Osteogenic Sarcoma of the Jaws

Classification of Odontogenic Carcinomas

Histologic Features of an Ameloblastic Carcinoma

The Symptomatic-Anatomic-Comorbid (SAC) Staging System of Feinstein et al for Cancer of the Larynx

Composite Laryngeal Recurrence Staging System (CLRSS) of Lacy and Piccirillo for Recurrent Laryngeal Squamous Cell Carcinoma

TNM Staging of Bhattacharyya for Tracheal Carcinoma

Criteria of Lewis et al for Basaloid Squamous Cell Carcinoma (BSCC) of the Larynx

Prognosis in Medullary Carcinoma of the Thyroid

Staging for Papillary and Follicular Thyroid Carcinoma

MACIS Prognostic Score for Papillary Thyroid Carcinoma

AMES Prognostic Groups in Patients with Thyroid Carcinoma

The EORTC Thyroid Cancer Cooperative Group Prognostic Index for Thyroid Carcinoma

The AGES Prognostic Score for Papillary Thyroid Carcinoma

Prediction of Malignancy for Nonfollicular Thyroid Neoplasms Based on the Ultrasound Features of Koike et al

Risk Factors from the NCCN Guidelines for Stratifying Patients with a Well-Differentiated Thyroid Cancer

Prognostic Factors of Shoup et al for a Patient with Metastatic Differentiated Thyroid Carcinoma

The VAN and SAG Scores of Akslen for Evaluating a Patient with a Papillary Thyroid Carcinoma

Indicators of Ohshima et al for Performing a Bilateral Modified Radical Neck Dissection in a Patient with a Papillary Thyroid Carcinoma

Clinical Findings Suspicious for Thyroid Carcinoma in a Euthyroid Patient with a Solitary Thyroid Nodule

Prognostic Factors of Cushing et al for a Patient with Well-Differentiated Thyroid Carcinoma

Pretreatment and Posttreatment Scores of Yildirim for Predicting Risk in a Patient with a Differentiated Thyroid Carcinoma

Staging System of Shin et al for a Papillary Thyroid Carcinoma with Local Airway Invasion

Risk Factors of Ghossein et al for Recurrence of an Encapsulated Hurthle Cell Carcinoma of the Thyroid Gland

Quantitative Alternative to the TNM Stage (QTNM) for Differentiated Thyroid Cancer

Strategy of Pacini et al for Monitoring a Patient with a History of Differentiated Thyroid Carcinoma

Prognostic Factors of Sugitani and Fujimoto for a Patient with a Papillary Microcarcinoma of the Thyroid Gland

Prognostic Index of Sugitani et al for a Patient with Anaplastic Thyroid Carcinoma

Prognostic Factors of Lopez-Penebad et al for a Patient with a Hurthle Cell Neoplasm of the Thyroid

1992 TNM Classification and Staging of Lung Carcinoma

Prognostic Staging System of Sagman et al for Small Cell (Oat Cell) Carcinoma of the Lung

Prognostic Factor Risk Index of Shinkai et al for Advanced Non-Small-Cell Lung Cancer

Prognostic Index of Wigren et al for a Patient with a Non-Small Cell Lung Cancer

Criteria for Pulmonary Neuroendocrine Tumors

Clinical Severity Staging System for Lung Cancer of Feinstein and Wells

Prognostic Factors of Beasley et al for Pulmonary Atypical Carcinoid Tumors

Modified Scar Grade of Maeshima et al for Small Peripheral Lung Adenocarcinomas

Clinical Features of the Pancoast Syndrome in a Patient with Lung Cancer

Criteria of Gal et al from the AFIP for Pulmonary Fibrohistiocytic Tumors

Prognostic Factors of Albain et al from the Southwest Oncology Group (SWOG) for Extensive-Stage Non-Small-Cell Lung Cancer

Prognostic Factors of Paesmans et al for a Patient with Advanced Non-Small-Cell Lung Cancer

Prognostic Factors of Suzuki et al for a Patient with a Surgically Resected Non-Small Cell Lung Carcinoma

Grading Criteria of Suzuki et al for Non-Small Cell Carcinomas of the Lung

Model of Hoang et al for Predicting Survival in a Chemonaive Patient with Advanced Non Small Cell Lung Cancer Treated with Platinum-Based Doublet Chemotherapy

Pretreatment Prognostic Score of Maestu et al for a Patient with Small Cell Lung Cancer

Prognostic Factors of Takigawa et al for a Patient with Advanced Non-Small Cell Lung Cancer (NSCLC)

Prognostic Index of Vincent et al for Small Cell Lung Cancer

Prognostic Model of Cerny et al for a Patient with a Small Cell Lung Cancer (Manchester Score)

Prognostic Model of Souhami et al for a Patient with Small Cell Carcinoma of the Lung

Prognostic Model of Mandrekar et al for Advanced Non-Small Cell Lung Cancer (NSCLC)

Monitoring Serum Neuron-Specific Enolase (NSE) in a Patient with a Small Cell Carcinoma of the Lung

Prognostic Scores of Forrest et al for a Patient with Inoperable Non-Small-Cell Carcinoma of the Lung (Glasgow Prognostic Score)

Prognostic Indices of Muers et al for a Patient with Non-Small Cell Lung Cancer

Criteria of Martini and Melamed for the Diagnosis of Synchronous Primary Lung Carcinomas

Prognostic Factors of Ou et al for Survival in a Patient with Non-Small Cell Lung Cancer

Model of Park et al for Predicting Outcome for a Patient with a Nonsmall Cell Lung Cancer Treated with Gefitinib As Salvage Therapy

Risk Factors for Lung Cancer

Endobronchial Carcinoid Tumor Mimicking Asthma

Histologic Features of Kelsey et al Predictive of Local Recurrence in a Patient Following Surgery for Early Stage Nonsmall Cell Lung Cancer

Immunohistochemical Score of Ring et al for Classification of Non-Small Cell Lung Carcinoma

Hazard Score of Yamaguchi et al for Determining the Prognosis for a Patient with an Adenocarcinoma of the Lung

Prognostic Molecular Markers of Lu et al for a Patient with Stage I Non-Small Cell Lung Cancer (NSCLC)

Presenting Signs and Symptoms for a Patient with Lung Cancer

Clinical and Laboratory Findings of Metastatic Disease in a Patient with Lung Cancer

Paraneoplastic Syndromes Seen in Patients with Lung Cancer

Predictive Factors of Ando et al for Antitumor Response and Survival in a Patient with Non-Small Cell Lung Cancer Treated with Gefitinib

Prognostic Factors of Paesmans et al for a Patient with a Small Cell Lung Carcinoma (SCLC)

Algorithm of Rekhtman et al for Using Immunostains to Classify a Non-Small Cell Lung Carcinoma (NSCLC)

Algorithm of Cheng et al for Molecular Testing of a Lung Adenocarcinoma, Starting with EGFR Mutation Testing

Algorithm of Cheng et al for Molecular Testing of a Lung Adenocarcinoma, Starting with KRAS Mutation Testing

Prognostic Factors of de Cos Escuin et al for a Patient with Stage III Non-Small Cell Lung Cancer Undergoing Combined Chemotherapy and Radiation

False-Positive and False-Negative Findings for Lung Cancer Associated with Positron Emission Tomography (PET)

Distinguishing Pulmonary Enteric Adenocarcinoma from Metastatic Colorectal Adenocarcinoma

Primary Adenoid Cystic Carcinoma (ACC) of the Lung

Staging System of the Veterans Administration Lung Cancer Study Group (VALCSG) for Small Cell Lung Carcinoma (Limited versus Extensive Stage Disease)

Stent Placement to Relieve Major Airway Obstruction Caused by a Lung Tumor

Indications to Perform a Pleurodesis in a Patient with Lung Cancer and a Malignant Pleural Effusion

Monitoring Response to Pleurodesis for Malignant Pleural Effusion in a Patient with Lung Cancer

Significance of a Pleural Fluid Accumulation in a Patient with a Localized Lung Cancer

Circulating Tumor Cells (CTC) in a Patient with Lung Cancer

Predictors of Prevost et al for Mortality in a Patient with a Non-Small Cell Lung Cancer (NSCLC)

Detection of an EGFR Mutation in a Non-Small Cell Lung Carcinoma Using Immunohistochemistry (IHC)

Detection of the EML4-ALK Translocation in Lung Adenocarcinoma Using the Vysis ALK Break Apart FISH Probe

Visceral Pleural Invasion (VPL) in Lung Cancer

N Stage for a Lung Cancer and the International Association for the Staging of Lung Cancer (IASLC) Lymph Node Map

Adrenalectomy for an Isolated Metastasis from a Non-Small Cell Lung Carcinoma

Histologic Subtypes of Sarcomoid Carcinoma of the Lung

Score of Barletta et al for Grading a Lung Adenocarcinoma

Criteria of Machtay et al for Local-Regional Failure Following Radiation Therapy in a Patient with Lung Cancer

Risk Factors of Higginson et al for Palliative Thoracic Radiation Therapy Following First-Line Chemotherapy in a Patient with Advanced Non-Small Cell Lung Carcinoma

Recommendations for Annual Lung Cancer Screening from the Lung Cancer Guidelines Third Edition (LCIII) of the American College of Chest Physicians (ACCP)

Clinical Staging System for Thymoma of Masaoka et al

Prognostic Analysis of Thymoma of Pescarmona et al

TNM Classification for Thymoma

Prognostic Factors of Zisis et al for Survival in a Patient with a Completely Resected Thymic Epithelial Tumor

World Health Organization (WHO) Histologic Classification for a Thymic Epithelial Tumor

Prognostic Factors of Burke et al for Primary Sarcomas of the Heart

Elston's Modification for the Criteria of Bloom and Richardson in the Histologic Grading of Infiltrating Ductal Carcinoma

Prognostic Index of Haybittle et al for Infiltrating Ductal Carcinoma (Nottingham Prognostic Index, NPI)

Van Nuys Prognostic Index for Ductal Carcinoma In Situ

TNM Classification and Clinical Staging of Breast Carcinoma

Prognostic Factors in Breast Carcinoma

Scoring Breast Cosmesis Following Therapy

Absolute and Relative Contraindications to Breast Conservation Treatment with Radiation

Relative Risk for Subsequent Invasive Breast Cancer Associated with Changes Seen in Breast Biopsies

Evaluating a Woman's Risk of Developing Breast Cancer Based on Her Family's Cancer History

Grading Ductal Carcinoma in Situ Using the AFIP System of Tavassoli et al

Prognostic Score of Chevallier et al for Histological Node Negative Breast Carcinoma

Prediction of Metastases to Axillary Lymph Nodes in Women with Invasive Breast Carcinoma

The Model of Gail et al for Predicting the Probability of Developing Breast Cancer in White Women Examined Annually: Calculating the Relative Risk

The Model of Gail et al for Predicting the Probability of Developing Breast Cancer in White Women Examined Annually: Calculating the Absolute Risk

The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: First Degree Relatives with Breast Cancer

The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Mother and Aunt with Breast Cancer

The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Second Degree Relatives with Breast Cancer

The Model of Claus et al for Predicting Cumulative Probability of Breast Cancer: Relatives with Ovarian Cancer

The Prognostic Index of Yamamoto et al for Women with Metastatic Breast Carcinoma

Factors of Lambert et al for Predicting Nipple Involvement in Women with Breast Cancer

Standardized Instrument of Petrek et al for Detecting Lymphedema in a Patient with Breast Cancer Following Axillary Lymph Node Dissection

The Triple Test Score (TTS) for Palpable Breast Masses

Criteria of Rosen for Identification of Lymphatic Tumor Emboli in Breast Carcinoma

Histologic Grading of Phyllodes Tumor

2 mm Size Rule of Tavassoli for Ductal Carcinoma in Situ (DCIS)

Factors Associated with Response to Neoadjuvant Chemotherapy in Women with Breast Carcinoma

Infiltrating Ductal Carcinoma with Extensive Ductal Carcinoma in Situ (DCIS)

The Modified Triple Test Score (MTTS) for a Palpable Breast Mass

Probability of Successful Mapping of the Axillary Sentinel Lymph Nodes for Breast Cancer Based on the Woman's Age and Body Mass Index (BMI)

Risk Factors for Breast Cancer in a Male

Decision Tree of Banerjee et al for Prognosis in Women with Breast Cancer

Clinical Factors of Clarke et al Affecting the Cosmetic Result in a Woman with Stage I or II Breast Cancer Treated by Biopsy and Irradiation

Indications for Performing a Mastectomy in a Woman with a Phyllodes Tumor

Nucleus Fibrotic Focus Fat Invasion (NNF) Classification of Hasebe et al for Invasive Ductal Carcinoma of the Breast

Model of Kattan et al for Predicting Mortality in a Woman with Breast Cancer Who Does Not Receive Adjuvant Therapy

Histologic Features of Stalsberg and Harmann for Infiltrating Tubular Carcinoma of the Breast Associated with Good Prognosis

Risk Categories from the 1998 St. Gallen Conference for Node Negative Breast Cancer in a Woman

Prognostic Factors of Kuru et al for Node Negative Breast Carcinoma in a Woman

Risk Categories from the 2001 St. Gallen Conference for Node Negative Breast Cancer in a Woman

Treatment Recommendations for a Woman with Operable Breast Cancer From the 2001 St. Gallen Conference

Model of Viale et al for Predicting Risk of Metastasis to Axillary Sentinel Lymph Nodes in a Patient with Breast Cancer

M.D. Anderson Prognostic Index (MDAPI) for Selecting a Woman with Breast Cancer for Breast Conserving Therapy After Neoadjuvant Chemotherapy

Risk Factors of Stolier and Grube for Nipple or Areola Involvement in a Woman with Primary Breast Carcinoma

Risk Factors of Gonzalez-Angulo et al Predictive for Distant Metastases in a Woman with Breast Cancer and a Complete Response to Neoadjuvant Chemotherapy

Nomogram of Hennessy et al for Predicting Residual Tumor in Axillary Lymph Nodes Following Primary Chemotherapy for Breast Carcinoma

Nomogram of Rouzier et al for Predicting Complete Pathologic Response of a Breast Cancer to Preoperative Anthracycline Chemotherapy

Nomogram of Rouzier et al for Predicting the 5 and 10 Year Probabilities of Freedom from Distant Metastasis in a Woman with Residual Breast Cancer After Preoperative Anthracycline Chemotherapy

Histologic Grading of Lobular Carcinoma of the Breast Using the Bloom Richardson Score

Histologic Grades of Donnell et al for Angiosarcoma of the Breast

Factors of Chen et al for Identifying Increased Risk of Supraclavicular Lymph Node Metastases in Breast Carcinoma

Criteria of Isaacs et al for Counseling and Testing a Patient for BRCA1 and BRCA2 Mutations

Risk Factors of Dillon et al for Predicting Invasive Breast Cancer in a Woman with DCIS on Core Biopsy

Pedigree Assessment Tool (PAT) of Hoskins et al for Identifying a Woman at High Risk for Hereditary Breast Cancer

Predictors of Huo et al for Invasive Carcinoma in a Patient with Ductal Carcinoma in Situ (DCIS) Diagnosed on a Needle Core Biopsy

Tamoxifen Indication Score (TIS) of Rahman et al for a Woman with Breast Cancer

Criteria of Silver and Tavassoli for Minimally Invasive (Microinvasive) Breast Carcinoma

Histologic Features of Pleomorphic Invasive Lobular Carcinoma

Nomogram of Bevilacqua et al for Predicting Metastases to a Sentinel Lymph Node

J-Score for Reporting Estrogen Receptor Status by Immunohistochemistry for a Woman with Breast Cancer

Nomogram of Hanrahan et al for Survival in a Woman with a T1a,bN0M0 Breast Carcinoma

Allred Score for Reporting Estrogen Receptor Status by Immunohistochemistry for a Woman with Breast Cancer

Score of Acs et al for E-Cadherin Immunostaining in a Breast Carcinoma

Nomogram of Katz et al for Identifying a Woman with Breast Cancer and a Positive Sentinel Lymph Node Biopsy Who Probably Has Metastases in 4 or More Lymph Nodes

Clinical-Pathologic Scoring System (CPS and CPS+EG) of Jeruss et al for Evaluating a Woman with Breast Cancer After Neoadjuvant Therapy

N+P (Nuclear Grade and Proliferation Index) Scheme of Tawfik et al for Grading Invasive Ductal Carcinoma

Tenon Axillary Scoring System of Barranger et al for Predicting Metastasis Status of Non-Sentinel Axillary Lymph Nodes in a Woman with Breast Cancer

Reasons for a Delay in the Diagnosis of Breast Cancer

Distinguishing Lobular from Ductal Carcinoma By Use of Immunostains to E-Cadherin and High Molecular Weight Cytokeratin

The N+P Histologic Grading System of Stevens et al for Invasive Lobular Carcinoma

Risk Factors of Rowell for Locoregional Recurrence (LRR) in a Woman with Node-Negative Breast Cancer

Risk Factors of Cheng et al for Locoregional Recurrence (LRR) in Women with T1 or T2 N1M0 Breast Cancer

Model of Kohrt et al for Predicting Non-Sentinel Lymph Node Status in a Woman with Breast Cancer and a Positive Sentinal Lymph Node (Stanford Online Calculator)

Model of Ratanawichitrasin et al for Predicting the Likelihood of Residual Ductal Carcinoma in Situ (DCIS) Following Therapy

Risk Model of Wallgren et al for Locoregional Recurrence in a Woman Treated for Breast Cancer

Indications of O'Shaughnessy for Performing Ductal Lavage on a Woman

Criteria of Ridolfi et al for Medullary Carcinoma of the Breast

Management Protocol of O'Shaughnessy et al for a Woman at High Risk for Breast Cancer Based on Ductal Lavage Cytology Results

Prognostic Factors of Carter et al for a Woman with Invasive Breast Cancer

Criteria of Hughes at al for Providing Additional Therapy to a Woman with Ductal Carcinoma in Situ (DCIS)

Grading System of Hasebe et al for Lymphatic Tumor Emboli in a Woman with Invasive Ductal Carcinoma

Model of Graesslin et al for Predicting the Risk of Brain Metastases in a Woman with Metastatic Breast Cancer

Nomogram of Rudloff et al for Predicting Local Recurrence Risk Following Breast Conserving Therapy for Ductal Carcinoma in Situ (DCIS)

Criteria of Tavassoli for Atypical Papilloma and Carcinoma Arising in a Papilloma

Pathologic Features of an Angiosarcoma of the Breast

Clinical Presentation of Paget's Disease of the Nipple

Prognostic Factors of Panet-Raymond et al for a Woman with Recurrent Cancer in the Ipsilateral Breast

Risk Factors of Pimiento et al for Local Recurrence of a Phyllodes Tumor

Risk Factors of Brinton for Breast Cancer in a Male with Klinefelter's Syndrome

Classification of Ragazzi et al for Mitochondrial Content of Oncocytic and Other Invasive Breast Carcinomas

Gene Expression Patterns of Sorlie et al for Breast Carcinoma

Nomogram of Timmers et al for Identifying a Woman with Breast Cancer Based on Findings Identified on Screening Mammography

Histologic Parameters for Grading Squamous Cell Carcinoma of the Esophagus

Clinical Risk Factors for Adenocarcinoma Arising in Barrett's Esophagus

Revised TNM Classification of Eloubeidi et al for Esophageal Carcinoma Based on Tumor Length

Grading Histologic Tumor Regression Following Preoperative Chemoradiotherapy for Esophageal Carcinoma

Prognostic Index of Chau et al for Patients with Locally Advanced or Metastatic Esophago-Gastric Cancer

Prognostic Factors of Rades et al for Overall Survival in a Patient with a Stage II or III Esophageal Carcinoma

Indications for Endoscopic Mucosal Resection (EMR) of a Superficial Carcinoma of the Esophagus

Classification of Siewert et al for Adenocarcinoma at the Gastroesophageal Junction

Risk Factors of Sauvanet et al for Complications in a Patient Undergoing Surgical Management of an Adenocarcinoma at the Gastroesophageal Junction (GEJ)

Classification of Radical Resections (R) for Adenocarcinoma at the Gastroesophageal Junction (GEJ)

Risk Score of Steyerberg et al for 30 Day Mortality After Surgery for Esophageal Cancer

Complications of Djarv et al Following Surgical Resection of an Esophageal Carcinoma

Prognostic Factors of Yendamuri et al Determining Survival for a Patient with Esophageal Cancer

Prognostic Score of Marubini et al in Gastric Carcinoma

TNM Staging of Gastric Carcinomas

Prognostic Factors of Shiu et al for Adenocarcinoma of the Stomach

Prognostic Factors of Okada et al for Adenocarcinoma of the Stomach

Classification of the Gross Appearance in Gastric Carcinomas (Early and Borrmann Types)

Treatment Algorithm of Lowy et al for Gastric Cancer

Risk Factors of Marrelli et al for Liver Metastases After Surgical Resection of a Gastric Adenocarcinoma

Postoperative Nomogram of Kattan et al for Predicting Disease-Specific Survival in a Patient With Gastric Carcinoma and No Residual Disease (R0)

Indications of Soetikno et al for Endoscopic Mucosal Resection (EMR) of a Superficial Gastric Carcinoma

Postrecurrence Risk Score of Bennett et al for Predicting Survival in a Patient with Recurrent Gastric Carcinoma

Criteria of Gotoda et al for Local Therapy of an Early Gastric Cancer

Prognostic Factors of Adachi et al for a Patient with an Alpha Fetoprotein (AFP) Producing Gastric Carcinoma

Criteria for the Diagnosis of Hereditary Diffuse Gastric Cancer

Risk Factors of Persiani et al for Complications After Surgery for Gastric Cancer

Prognostic Factors of Kooby et al for a Patient with Gastric Carcinoma and Negative Lymph Nodes

Flow Diagram of Lee et al for Laparoscopic Wedge Resection of a Gastric Submucosal Tumor

Prognostic Model of Lorenzen et al for Patients with Gastric Cancer

TNM Staging of Colon Cancer

Doubling Time of CEA Concentrations and Prognosis in Recurrent Gastric and Colorectal Carcinoma

Prognostic Score of Diez et al for Colorectal Adenocarcinoma Based on Histopathologic Features

Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Lynch Classification

Grading and Prognostic System for Rectal Carcinoma of Jass et al

Lifetime Risk for Colorectal Carcinoma According to Houlston et al

West Midlands Screening Criteria for a Person with a Family History of Colorectal Carcinoma

Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Original and Revised Bethesda Guidelines

Management of the Patient with Adenocarcinoma in a Colonic Adenomatous Polyp

Risk Factors of Nascimbeni et al for Predicting Lymph Node Metastasis in Patients with T1 Carcinoma of the Colon or Rectum

Cumulative Prognostic Index of Petersen et al for a Patient with Duke's B Colon Carcinoma

UK National Health Service (NHS) and Department of Health Risk Criteria for Colon Cancer

Risk Factors of Merkel et al for Patients with Stage II Colon Carcinoma

Criteria of Bouzourene et al for Assessment of Tumor Regression After Preoperative Radiotherapy of Locally Advanced Rectal Carcinoma

Prognostic Index of Graf et al for Patients with Advanced Colorectal Carcinoma

Risk Stratification Tree of Radespiel-Troger et al for Predicting Recurrence After Curative Resection of Colon Carcinoma

Criteria of Cooper for the Diagnosis of a Squamous Cell Carcinoma of the Colon or Rectum

Risk Factors of Fujimoto et al for Liver Metastases in a Patient with Colorectal Carcinoma

ACPGBI (Association of Coloproctology of Great Britain and Ireland) Score for Predicting Mortality in a Patient Undergoing Resection of a Colorectal Cancer

Predictors of Das et al for Downstaging a Rectal Cancer Treated with Preoperative Chemoradiation

Hereditary Nonpolyposis Colorectal Cancer (HNPCC): Amsterdam Criteria

Prognostic Factors of Gervaz et al for a Cirrhotic Patient with a Colorectal Adenocarcinoma

Use of the Bethesda Panel to Determine Microsatellite Instability (MSI) in a Colorectal Carcinoma

Molecular Classification of a Colorectal Carcinoma Based on Microsatellite Instability (MSI) and CpG Island Methylator Phenotype (CIMP)

Histologic Features Suggestive of Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC)

Indications for K-ras Testing and Cetuximab Therapy for a Patient with Colorectal Cancer

Clinical Signs and Symptoms in a Patient with Colorectal Carcinoma

Sites of Metastases in a Patient with Colorectal Cancer

Criteria of Loy and Kaplan for Villous Adenocarcinoma of the Colon

Steps to Prevent Colorectal Cancer

Recommendations of Ribic et al for Identifying a Patient with Colon Cancer Who Is a Candidate for Fluorouracil-Based Adjuvant Chemotherapy Using Stage and Microsatellite Instability Status

Factors Affecting the Number of Lymph Nodes Retrieved in a Colectomy Specimen Resected for Colon Carcinoma

Log Odds of Positive Lymph Nodes (LODDS) in a Patient with Colon Cancer

Classification of Pai et al for Mucinous Neoplasms of the Appendix

Nomograms of Weiser et al for Predicting Survival in a Patient Following Curative Colectomy for Colon Cancer: Nomograms A and B

Nomograms of Weiser et al for Predicting Survival in a Patient Following Curative Colectomy for Colon Cancer: Nomogram C

Screening a Patient for Colorectal Adenoma or Cancer with Plasma SEPT9 (Septin 9) Methylated DNA

Immunohistochemical Demonstration of DNA Mismatch Repair (MMR) Proteins to Identify a Patient with Lynch Syndrome (Hereditary Nonpolyposis Colon Cancer, HNPCC)

Molecular Biomarkers in a Patient with Metastatic Colon Cancer Being Considered for Targeted Therapy with a Monoclonal Antibody to EGFR

Predicting Survival in a Patient with Stage IV Colorectal Cancer Using the Glasgow Prognostic Score (GPS)

Immunohistochemical Algorithm of Neumann et al for Determining the Risk of Distant Metastases in a Patient with a Cancer Arising in the Right Colon

Criteria of Li et al for Testing for BRAF Mutations in a Colorectal Cancer

Prognostic Factors in Extragastrointestinal Stromal Tumors

Risk Factors of Fletcher et al for Aggressive Behavior in Gastrointestinal Stromal Tumors (GIST)

Diagnosis of Spindle Cell Tumors of the Gastrointestinal Tract with Immunoperoxidase Staining

Gastrointestinal Stromal Tumor (GIST) Risk Score of Nilsson et al

Risk Factors of Van Glabbeke et al for Early or Late Resistance to Imatinib in a Patient with a Gastrointestinal Stromal Tumor (GIST)

Phenotypic Changes in a Gastrointestinal Stromal Tumor (GIST) After Therapy with Imatinib Mesylate

Criteria of Yokoi et al for Malignancy in a Gastrointestinal Stromal Tumor (GIST)

Predictors of DeMatteo et al for Recurrence of a Localized Gastrointestinal Stromal Tumor (GIST) Following Resection

Clinical Staging System of Woodall et al for Gastrointestinal Stromal Tumors (GIST)

Risk Categories of Joensuu for a Gastrointestinal Stromal Tumor (GIST)

Prognostic Nomogram of Gold et al for a Gastrointestinal Stromal Tumor (GIST)

Okuda Staging System for Hepatocellular Carcinoma

Prognostic Factors in Advanced Hepatocellular Carcinoma

Prognostic Score of Iwatsuki et al to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation

Algorithm of Terkivatan et al for the Management of a Solitary Solid Liver Tumor

Hepatocellular Prognostic Index (HPI) of Lauwers et al for Patients with Completely Resected Hepatocellular Carcinomas

The Chinese University Prognostic Index (CUPI) for Hepatocellular Carcinoma

Molecular Classification of Hepatocellular Carcinoma Based on Estrogen Receptor Transcripts

Prediction Score of Yamanaka et al for Selecting Surgical Treatment of Liver Cancer

Prognostic System of the Cancer of the Liver Italian Program (CLIP)

Simplified T Classification of Vauthey et al for Hepatocellular Carcinoma

TNM Classification for Hepatocellular Carcinoma

The Pretreatment Extent of Disease (PRETEXT) System for Describing Hepatocellular Carcinoma

Criteria for Response to Therapy of the International Society of Pediatric Oncology Group for a Patient with Hepatocellular Carcinoma

The Barcelona-Clinic Liver Cancer (BCLC) Staging Classification for Hepatocellular Carcinoma

The French Classification of Chevret et al for Hepatocellular Carcinoma (GETCH Score)

Clinical Prognostic Model of Tan et al for Hepatocellular Carcinoma

Monitoring Strategy of Bruix et al for Hepatocellular Carcinoma in a Patient with Cirrhosis

Classification of the Children's Cancer Study Group (CCSG) for Hepatoblastoma

CAP (C-Reactive Protein, Albumin, Platelet Count) Score of Hashimoto et al for a Patient with Hepatocellular Carcinoma

Prognostic Score of Pawlik et al for Predicting Survival After Resection of a Large Hepatocellular Carcinoma

Criteria of Arrieta et al for the Diagnosis of Hepatocellular Carcinoma in a Patient with Cirrhosis Based on Serum Alpha Fetoprotein (AFP) Levels

Prognostic Index of Ikai et al for a Hepatocellular Carcinoma with a Tumor Thrombus in a Major Portal Vein

Modified Japan Integrated Scoring System (JISS) for a Patient with Hepatocellular Carcinoma

Prognostic Factors of D'Antiga et al for a Patient with a Hepatoblastoma

Milan Criteria for Liver Transplantation in a Patient with Cirrhosis and Small Hepatocellular Carcinomas

University of California San Francisco (UCSF) Criteria for Liver Transplantation in a Patient with Cirrhosis and Small Hepatocellular Carcinomas

Prognostic Model of Tateishi et al for Hepatocellular Carcinoma (Tokyo Score)

Prognostic Factors of Liang et al for Survival Following Percutaneous Microwave Ablation of an Hepatocellular Carcinoma

Pathological Score of Parfitt et al for Predicting Recurrent Hepatocellular Carcinoma Following Liver Transplantation

Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model A

Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model B

Models of Yang et al for Predicting the Risk of Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B: Model C

Invasiveness Score of El-Assal et al for Predicting Recurrence of a Hepatocellular Carcinoma After Curative Resection

V-CLIP Scoring System of Kaseb et al for a Patient with Hepatocellular Carcinoma (HCC)

Predictive Index for PVTT in HCC (PITH) of Yu et al.

Score of Jun et al for Predicting Extrahepatic Metastasis in a Patient with Hepatocellular Carcinoma Following Curative Hepatectomy

Diagnosis of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis Using the Serum Tumor Marker Score of Ramage et al

TNM Staging System of Okabayashi et al for Intrahepatic Cholangiocarcinoma

Classification of Bismuth and Corlette for Hilar Cholangiocarcinoma

Criteria for Identifying an Intrahepatic or Perihilar Cholangicarcinoma as Unresectable

Risk Factors for Carcinoma of the Gallbladder

Prognostic Factors of Baton et al for Survival After Major Hepatectomy for Hilar Cholangiocarcinoma Type 3 or 4 (Advanced Klatskin Tumor)

Risk Factors of Shaib et al for Cholangiocarcinoma

Prognostic Index of Park et al for Advanced Biliary Tract Adenocarcinoma

Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma

Tata Memorial Hospital Scoring System (TMHSS) for Gallbladder Cancer

Tumor Recurrence Prognostic Index (TRPI) of Hong et al for a Patient Following Liver Transplantation for Intrahepatic or Hilar Cholangiocarcinoma

Prognostic Factors of de Jong et al for a Patient with an Intrahepatic Cholangiocarcinoma

Model of Barr Fritcher et al for Evaluating a Patient with a Pancreatobiliary Stricture for the Risk of Malignancy

Nomogram of Wand et al for a Patient with Intrahepatic Cholangiocarcinoma Following Partial Hepatectomy

Prognostic Factors of Geer and Brennan in Patients with Pancreatic Adenocarcinoma

Prognostic Index of Ikeda et al for Patients with Locally Advanced, Nonresectable Pancreatic Carcinoma

Clinical and Laboratory Findings Associated with Poor Prognosis in Patients with Pancreatic Adenocarcinoma

Management Options for a Patient with Pancreatic Adenocarcinoma

Prognostic Index of Sawaki et al for a Patient with Metastatic Pancreatic Cancer Treated with Gemcitabine

Contraindications for Attempting Surgical Resection of a Pancreatic Adenocarcinoma

Cytologic Grading System of Eltoum et al for Pancreatic Adenocarcinoma

Nomogram of Ferrone et al for Disease-Specific Survival After Resection of a Pancreatic Adenocarcinoma

Risk Factors of Ferrone et al Associated with Survival in a Patient with Resectable Pancreatic Adenocarcinoma

Histologic Grading System of Hruban and Fukushima for a Pancreatic Adenocarcinoma

Histologic Features to Help Determining if Pancreatic Glands Are Benign or Malignant

Criteria of Small et al for Response to Therapy in a Patient with a Pancreatic Cancer

Risk Factors of Siddiqui et al for Early Mortality in a Male Military Veteran with Pancreatic Carcinoma

Serum CA125 and CA19-9 in a Patient with Pancreatic Disease

M.D. Anderson Criteria for Resectability of a Pancreatic Carcinoma

McGill-Brisbane Symptom Score for Evaluating a Patient with Pancreatic Adenocarcinoma

Prediction Rule of Cai et al for Estimating the Risk of Pancreatic Cancer in a Patient with Chronic Pancreatitis and a Focal Mass Lesion

Adenosquamous Carcinoma of the Pancreas

TNM Classification of Carcinoma Arising at the Ampulla of Vater

Prognostic Factors of Kau et al for Periampullary Carcinomas

Prognostic Factors of Carter et al for an Adenocarcinoma at the Ampulla of Vater

Risk Factors in Rectal Carcinoid Tumors

Indications for Hemicolectomy in a Patient with an Appendiceal Carcinoid Tumor

Clinical Features of the Zollinger-Ellison Syndrome Associated with Neuroendocrine Gastrin Hypersecretion (Gastrinoma, Islet Cell Hyperplasia)

Vasoactive Intestinal Peptide Secreting Tumor (VIPoma, Pancreatic Cholera, WDHA)

Clinical Features of an Insulinoma

Clinical Features of the Glucagonoma Syndrome

Clinical Features of the Somatostatinoma Syndrome

Clinical Features of the Carcinoid Syndrome

Prognostic Factors of Shebani et al for Carcinoid Tumors Arising in the Gastrointestinal Tract

Prognostic Classification of Hochwald et al for Pancreatic Endocrine Neoplasms

Histologic Types of Solcia et al for Pancreatic Endocrine Tumors

Criteria of Deshpande et al for a Malignant Pancreatic Endocrine Tumor

TNM Staging Scheme of Ellison et al for Gastrinoma

Prognostic Factors of Haider et al for a Patient with an Extrapulmonary Small Cell Carcinoma

Histologic Grading Scheme of Rindi et al for a Foregut Neuroendocrine Tumor

TNM Classification of Rindi et al for a Malignant Neuroendocrine Tumor Arising in the Pancreas

Prognostic Factors of Ferrone et al for a Pancreatic Endocrine Neoplasm

WHO Classification for Grading Pancreatic Endocrine Neoplasms

Predictors of Capella et al for the Behavior of an Endocrine Tumor of the Stomach

TNM Staging System of Landry et al for Appendiceal Carcinoid Tumors

TNM Staging System of Landry et al for a Colonic Carcinoid Tumor

Imaging Studies for Localizing a Neuroendocrine Tumor

Risk Factors of Panzuto et al for Disease Progression for a Patient with a Pancreatic Endocrine Carcinoma

Monitoring Serum Chromogranin A in a Patient with a Neuroendocrine Tumor

Nomogram of Modlin et al for Predicting Survival in a Patient with a Neuroendocrine Tumor of the Small Intestine

Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Hough et al

Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Weiss

Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Criteria of Slooten et al.

Clinical and Pathologic Features Distinguishing Adrenocortical Tumors

TNM Classification of Adrenal Cortical Carcinoma

Predictors of Stojadinovic et al for Disease Specific Survival in Patients with Adrenocortical Carcinoma

Separation of Benign vs Malignant Adrenal Cortical Tumors Based on the Modified Weiss Score of Aubert et al

Histomorphological and Molecular Criteria of Stojadinovic et al for Metastatic Adrenocortical Carcinoma

Algorithm of Blanes and Diaz-Cano for the Histopathologic Diagnosis of Proliferation Lesions of the Adrenal Cortex

Staging Criteria of Sandrini et al for a Childhood Adrenocortical Tumor

Fuhrman's Nuclear Grading System for Renal Cell Carcinoma

Modified Staging System of Robson for Renal Cell Carcinoma

TNM Staging System of the American Joint Committee on Cancer for Renal Cell Carcinoma

Prognostic Factors for Renal Cell Carcinoma

Prognostic Factors of Elson et al in Recurrent or Metastatic Renal Cell Carcinoma

Prognostic Factors of Motzer et al in Advanced Renal Cell Carcinoma

The UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma

Prognostic Factors of De Forges et al for Patients with Metastatic Renal Cell Carcinoma

Mathematical Model of Zisman et al for Predicting Survival in a Patient with Renal Cell Carcinoma

Risk Group Analysis Algorithm of Zisman et al for Predicting Outcome in Patients with Surgically Resected Renal Cell Carcinoma

Prediction Model of Leibovich et al for Patients with Clear Cell Renal Cell Carcinoma After Radical Nephrectomy

SANI Score of Leibovich et al for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma After Nephrectomy and Immunotherapy with Interleukin-2

Prognostic Factors of Motzer in Previously Treated Patients with Metastatic Renal Cell Carcinoma

Prognostic Factors of Malhi et al for Patients with Metastatic Renal Cell Cancer

Risk Score of Hanninen et al for a Patient with Metastatic Renal Cell Carcinoma

Prognostic Score of Palmer et al for a Patient with Advanced Renal Cell Carcinoma Treated with Recombinant Interleukin-2

The Stage, Size, Grade and Necrosis (SSIGN) Score of Frank et al for Predicting Survival in a Patient with a Clear Cell Renal Cell Carcinoma

Postoperative Prognostic Model of Kattan et al for a Patient with Renal Cell Carcinoma

Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Abdominal Recurrence Score

Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Thoracic Recurrence Score

Postoperative Model of Frank et al for Surveillance of a Patient with Clear Cell Renal Cell Carcinoma: Bone Recurrence Score

Prognostic Model of Atzpodien et al for Patients with Metastatic Renal Cell Carcinoma

Model of Yaycioglu et al for Recurrence Risk Following Resection in a Patient with Nonmetastatic Renal Cell Carcinoma

Recurrence Risk Formula (RRF) of Cindolo et al for Predicting the Risk of Recurrence in a Patient with Nonmetastatic Renal Cell Carcinoma

Prognostic Model of Donskov and von der Maase for a Patient with Metastatic Renal Cell Carcinoma

Algorithm of Leibovich et al for Predicting Survival in a Patient with Metastatic Clear Cell Carcinoma of the Kidney (Mayo Clinic Score and Tumor Thrombus Level)

Inflammation-Based Prognostic Score of Forrest et al for a Patient with Metastatic Renal Cancer (Glasgow Prognostic Score, GPS)

Algorithm of Oesterling et al for Management of a Patient with a Renal Angiomyolipoma

Algorithm of Liu et al for Distinguishing Different Types of Renal Cell Tumors Using Immunohistochemical Stains

Staging System of Ficarra for Locally Advanced Renal Cell Carcinoma

Nomogram of Lane et al for Chances of a Carcinoma in a Renal Tumor Removed By Partial Nephrectomy

Nomogram of Lane et al for Chances of an Aggressive Carcinoma in a Renal Tumor Removed By Partial Nephrectomy

Nomogram of Sorbellini et al for Predicting Recurrence After Resection of a Clear Cell Renal Cell Carcinoma

Aggressive Phenotypic Features of Amin et al for a Chromophobe Renal Cell Carcinoma

Diagnostic Features of a Chromophobe Renal Cell Carcinoma

Risk Factors of Moudouni et al for Adrenal Metastases in a Patient with Renal Cell Carcinoma

Prognostic Factors of Klatte et al for a Patient with a Clear Cell Renal Cell Carcinoma

Prognostic Implications of a Paraneoplastic Elevation of Serum Alkaline Phosphatase in a Patient with Renal Cell Carcinoma

Nomogram of Kutikov et al for Predicting Risk of Non-Cancer Death in a Patient with a Localized Renal Cell Carcinoma

Nomogram of Kutikov et al for Predicting Risk of a Cancer Death in a Patient with a Localized Renal Cell Carcinoma

Clinical and Pathologic Features of Renal Medullary Carcinoma

Prognostic Factors of Cheng et al for a Patient with a Renal Medullary Carcinoma

Prognostic Factors of Pichler et al for a Patient with Clear Cell Renal Cell Carcinoma

Prognostic Factors of Pichler et al for a Patient with Papillary Renal Cell Carcinoma

Predictors of Hudes et al for Poor Survival in a Patient with Metastatic Renal Cell Carcinoma

RENAL Nephrotomy Score of Kutikov and Uzzo

NWTS V Staging System for Wilms' Tumor

TNM Staging for Wilms' Tumor

Unfavorable Histologic Features in Wilms' Tumor

Radiographic Findings of Brisse et al for Preoperative Rupture of a Wilms Tumor

Histological and Cytological Grading of Urothelial Carcinomas

Risk Factors of Cheng et al Affecting Survival in Patients with Cancer of the Urinary Bladder Treated By Radical Cystectomy

Algorithm of Jarkrans et al for Classifying a Urothelial Bladder Cancer According to the Malmstrom Grading System

Criteria for Response to Therapy in a Urothelial Carcinoma of the Urinary Bladder

International Bladder Cancer Postoperative Nomogram of Bochner et al for Predicting Recurrence After Radical Cystectomy

Staging System of Sheldon et al for Urachal Carcinoma

Prognostic Index of Pomerance for a Carcinoma of the Urinary Bladder

Pathologic Criteria of Sheldon et al for a Urachal Neoplasm

Modified Staging System of Henly et al for Urachal Carcinoma (Mayo Staging System)

Clinical Findings Associated with a Urachal Carcinoma

Risk Factors Associated with Urothelial Carcinoma of the Urinary Bladder

Postoperative Nomograms of Shariat et al for the Prognosis Following Radical Cystectomy for Bladder Cancer

Algorithm of Margel for Predicting Pathologic Stage in a Patient with Organ-Confined Bladder Cancer by Clinical Evaluation

Prognostic Factors of Bellmunt et al for a Patient with Metastatic Transitional Cell Carcinoma That Is Refractory to Platinum-Based Chemotherapy

Nomogram of Jeldres et al for Predicting Survival for a Patient with an Upper Urinary Tract Urothelial Carcinoma

TNM Classification and Staging for Carcinoma of the Vulva

Risk Factors of Shah et al for Mortality in a Woman with Vaginal Cancer

TNM and FIGO Classification and Staging for Carcinoma of the Cervix Uteri

Histopathologic Score of Grisaru et al for Patients with Stage IA2, IB1 or IB2 Cervical Carcinoma

Histopathologic Scores of Lai et al for Patients with Stage IB or II Cervical Carcinoma

Histopathologic Risk Factors of Kamura et al for Women with Cervical Carcinoma

Prognostic Factors of Sevin et al for a Woman with Early Cervical Carcinoma

Risk Factors for Squamous Cell Carcinoma of the Cervix

Histologic Grading System of Kristensen et al for the Invasive Front in a Squamous Cell Carcinoma of the Cervix

Prognostic Factors of Kristensen et al for Early Squamous Cell Carcinoma of the Cervix

Distinguishing Endocervical from Endometrial Adenocarcinoma

Nomogram of Tseng et al for Predicting Survival of a Patient with Stage IIB to IVA Cervical Cancer

Score of Biewenga et al for Survival in a Patient with Cervical Cancer

Criteria for Squamous Differentiation and Malignancy in Endometrioid Adenocarcinoma

Histologic Grading of Uterine Endometrioid Adenocarcinoma

FIGO Staging for Uterine Corpus Carcinoma

Prognostic Scores of Ambros and Kurman for Endometrioid Adenocarcinoma

Risk Factors for Development of Endometrial Adenocarcinoma

Pathological Models of Zaino et al for Predicting Outcome in Stage I and II Endometrial Adenocarcinoma

A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma

Grading System of Alkushi et al for Endometrial Carcinoma

Pathologic Features of Scully et al for Malignant Tumors in Both the Endometrium and Ovary (Synchronous Primary vs Metastatic Carcinomas)

Risk Factors of Soliman et al for Synchronous Endometrioid Carcinomas of the Endometrium and Ovary

Risk Factors of Mariani et al for Lymph Node Metastasis in a Patient with Endometrial Carcinoma

Risk Factors of Prat for Lymph Node Metastases in a Woman with Endometrial Carcinoma. Modified from Boronow et al

Model of Todo et al for Predicting Lymph Node Metastases in a Woman with Endometrial Adenocarcinoma Based on Preoperative Risk Factors

Risk Factors Associated with Route of Recurrence in a Woman with Endometrial Adenocarcinoma

Risk Factors of Lampe et al for Pelvic Lymph Node Metastases in a Woman with Endometrial Adenocarcinoma

Preoperative Factors of Kang et al for Identifying a Patient at Risk for Lymph Node Metastases from an Endometrial Adenocarcinoma

Nomogram of Bendifallah et al for Predicting Lymph Node Metastases in a Woman with Stage I or Stage II Endometrial Cancer

Histologic Diagnosis of Uterine Smooth Muscle Tumors

Epithelioid Smooth Muscle Tumors of the Uterus

Pathologic Diagnosis of Endometrial Stromal Tumors

Prognostic Factors of Pautier et al for a Uterine Sarcoma

Nomogram of Zivanovic et al for Predicting 5-Year Survival Following Resection of a Uterine Leiomyosarcoma

TNM and FIGO Classifications for Cancer of the Fallopian Tubes

p53 Signature in the Fallopian Tube of a Woman with a BRCA Mutation

Scoring System of Schneider et al for Predicting Survival in Women with Advanced Ovarian Cancer

CA125 Prognostic Score in Women with Ovarian Cancer

Risk of Malignancy Index (RMI) of Jacobs et al for Ovarian Tumors

Risk of Malignancy Index (RMI) of Tingulstad et al for Ovarian Tumors

Ultrasound Scoring System of Sassone et al for Ovarian and Extrauterine Masses

Screening Protocol of Jacobs et al for Ovarian Cancer Using CA125 and Ultrasound

Ovarian Tumor Index of Twickler et al for Predicting the Risk of Malignancy

CT Predictive Index of Bristow et al for Surgical Outcome in Women with Advanced Ovarian Carcinoma

Histologic Grading System of Silverberg for Ovarian Epithelial Carcinomas

Models of Timmerman et al to Distinguish a Benign and Malignant Adnexal Mass Before Surgery: Complex Model M1

Models of Timmerman et al to Distinguish a Benign and Malignant Adnexal Mass Before Surgery: Simplified Model M2

Prognostic Factors of Bell et al for a Patient with an Ovarian Serous Borderline Tumor and Peritoneal Implants

Prognostic Index of Teramukai et al for Stage III or IV Epithelial Ovarian Cancer (PIEPOC)

Histologic Grading of Immature Teratoma of the Ovary

Prognostic Factors of Fox et al for a Woman with an Adult Granulosa Cell Tumor of the Ovary

Prognostic Factors of Bjorkholm and Silfversward for a Woman with an Ovarian Granulosa Cell Tumor

Two-Tier System of Malpica et al for Histologic Grading of an Ovarian Serous Carcinoma

Sonographic Criteria of Patel et al for an Ovarian Cystic Teratoma (Dermoid Cyst)

Risk Score of Chan et al for Relapse Free Survival for a Woman with an Epithelial Ovarian Cancer

Estrogen Production By Ovarian Tumors

Features of a Sex Cord Tumor with Annular Tubules Associated with Peutz-Jeghers Syndrome

Differential Diagnosis of an Elevated Serum CA 125 (Cancer Antigen 125) Level

Bowel Resection in a Woman with Ovarian Cancer

Clinical Symptoms Associated with Ovarian Cancer

Risk Factors of Dauplat et al for Distant Metastases in a Woman with an Epithelial Ovarian Carcinoma

Indicators of von Gruenigen et al for Worsening Prognosis in a Woman with Ovarian Cancer

Factors Identifying a Woman with Stage IV Ovarian Cancer Who May Benefit from Surgical Debulking

Predictors of Funt et al for Tumor Resectability in a Woman with Recurrent Ovarian Cancer

TNM and FIGO Staging of an Ovarian Carcinoma

Risk for Ovarian Cancer in a Patient with Endometriosis

Prognostic Factors of Fernandes et al for a Woman with Bowel Obstruction Secondary to Ovarian Cancer

Prognostic Factors of Sharma et al for a Woman with Advanced Ovarian Cancer

Score of Fagotti et al for Predicting Surgical Outcome in a Woman with Advanced Ovarian Cancer

Sonographic Score of Tailor et al for Predicting the Risk of Malignancy in an Adnexal Mass

Simple Ultrasound Rules of Timmerman et al to Decide If an Adnexal Mass Is Benign or Malignant

Weighted Scoring System of Lerner et al for Evaluating an Ovarian Mass By Transvaginal Ultrasonography (Modified Sassone Score)

Pulsatility Index (PI) in the Assessment of an Ovarian Neoplasm

Predictors of Hata et al for Malignancy in a Patient with an Ovarian Tumor

Logistic Model of Alcazar and Jurado for Predicting Malignancy in an Adnexal Mass

Risk of Ovarian Malignancy Algorithm (ROMA) of Moore et al for Predicting an Epithelial Ovarian Cancer

Prognostic Factors in Gestational Trophoblastic Disease

WHO Prognostic Index Score for Gestational Trophoblastic Disease

Staging of Gestational Trophoblastic Disease

Brewer Score for Gestational Trophoblastic Disease

Features Distinguishing Complete Mole, Partial Mole and Nonmolar Hydropic Change

Indications of Sebire and Seckl to Give Chemotherapy to a Woman with Gestational Trophoblastic Disease

Clinical Findings That May Be Presenting Features for Gestational Trophoblastic Disease

Jewett (AUS) and TNM Staging of Prostate Carcinoma

Prognostic Score of Pisansky et al for Clinically Localized Carcinoma of the Prostate

Histologic Grading of Radiation Effect on Prostate Carcinoma

Nomogram of Kattan et al for Prostate Cancer Recurrence Following 3D Conformal Radiation Therapy

Clinical-Anatomic Staging System of Clemens et al for Prostatic Cancer

Risk Analysis of Albertsen et al for Men Aged 55 to 74 Years at Diagnosis of Clinically Localized Prostate Cancer and Managed Conservatively

Postoperative Nomogram of Kattan et al for Risk of Recurrence After Radical Prostatectomy for Localized Prostate Carcinoma

Equation of Pisansky et al for Predicting the Likelihood of Metastases to Seminal Vesicles and/or Pelvic Lymph Nodes in a Patient with Prostate Cancer

Nomogram of Smaletz et al for Predicting Survival in a Patient with Metastatic Prostate Cancer After Castration

Nomogram of Kattan et al for Predicting 5 Year Probability of Metastasis Following Three Dimensional Conformal Radiation Therapy (CRT) for Localized Prostate Cancer

Nomogram of Kattan et al for Preoperative Prediction of Being Recurrence Free at 5 Years Following Radical Prostatectomy for Prostate Cancer

Equation of Lewis et al for the Total Volume of a Prostate Cancer Using the Extent of Tumor in Needle Biopsies and Serum PSA

Prognostic Indices of Wilson et al for Patients with Advanced Prostate Cancer

Models of Bostwick et al for Preoperative Prediction of Capsular Perforation and Seminal Vesicle Invasion in a Patient with Prostate Cancer

Nomogram of Kattan et al for Preoperative Prediction of Biochemical Progression at 5 Years in Clinically Localized Prostate Cancer Using Interleukin-6 Soluble Receptor and Transforming Growth Factor B

Criteria of Lara et al for the Response of Prostate Cancer to Therapy

Score of Salomon et al for Predicting Pretherapeutic Seminal Vesicle Invasion in a Patient with Prostate Cancer

Criteria of Epstein et al for Insignificant Prostate Carcinoma

Classification and Regression Tree (CART) Analysis of Garzotto et al for Identification of a Man at High Risk for Prostate Carcinoma

Probability of Prostate Cancer Specific Survival in a Patient with Biochemical Recurrence After Radical Prostatectomy Based on the Study of Freedland et al

Equations of Roach for Extent of Prostate Carcinoma Based on Serum PSA Concentration and Gleason Score

Criteria of Roach et al for Biochemical PSA Failure in a Patient with Prostate Cancer

Nomograms of Karakiewicz et al for Predicting the Probability of Cancer in a Prostate Biopsy

Nomogram of Halabi et al for Predicting Survival in a Man with Hormone Refractory Metastatic Prostate Cancer

Postoperative Nomogram of Stephenson et al for Predicting Recurrence Free Survival After a Radical Prostatectomy

Prognostic Model of Shulman and Benaim for Event-Free Survival (EFS) in a Man with Androgen-Independent Prostate Carcinoma

Predictors of Zhou et al for Cancer-Specific Mortality in a Male with Recurrent Prostate Cancer

Prognostic Scoring System of Buskirk et al for a Patient with Requiring Salvage Radiotherapy for Isolated PSA Increase After a Radical Prostatectomy

The University of California San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) Scoring System

Algorithm of Pound et al for Predicting the Chances of Being Free of Metastatic Disease Following Radical Prostatectomy for Prostate Cancer

Proposed Prostate Cancer Staging System of Roach et al

CART Model of Stephenson et al for Outcome Following Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

Nomogram of Stephenson et al for Predicting the Probability of Progression Free Survival Following Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

Model of Steyerberg et al for Prediction of Indolent Prostate Cancer

CPDR/CaPSURE Postoperative Equation of Moul et al for Prostate Cancer Recurrence

Nomogram of Nam et al for Predicting a Person's Risk of Having Prostate Cancer

Nomogram of Kulkarni et al for Predicting the Chances of an Upgrade in a Patient's Initial Gleason Score After Histologic Review

Model of Partin et al for Predicting Risk of Disease Recurrence Following Radical Prostatectomy

Preoperative Risk Recurrence Equations of Bauer et al for a Patient Undergoing Radical Prostatectomy

Nomogram of Nakanishi et al for Predicting a Low Grade and Low Volume Prostate Cancer

Nomogram of Walz et al for Comparing 10 Year Survival Following Radical Prostatectomy vs Radiotherapy in a Man with Prostate Cancer

Nomogram of Kattan et al for Predicting Survival in a Male with Clinically Localized Prostate Cancer That Is Managed Without Curative Intent

Measuring the Length of Needle Core Biopsies and the Amount of Prostate Cancer Present

Cytologic Features of Malignant Glands in a Patient with Prostate Adenocarcinoma

Evaluating the Adequacy of Needle Core Biopsies from the Prostate for the Diagnosis of Prostate Cancer

Histologic Patterns Seen at Low Power in a Prostate Biopsy

Gleason's Histologic Grades of Prostatic Adenocarcinoma

Predictors of Cheng et al for Survival in a Male with Prostate Cancer Following Radical Prostatectomy

Determining the Gleason Score for a Male with Prostate Cancer

Reporting the Secondary Pattern of a Prostate Cancer When Present in a Limited Amount Based on the 2005 ISUP Consensus Conference

Recommendations of the 2005 ISUP Consensus Conference for Reporting the Gleason Score for a Patient with Prostate Cancer If a Tertiary Pattern is Present

Risk Analysis of Gofrit et al for the Biopsy Gleason Score To Be Upgraded in the Prostatectomy Specimen

Nomogram of Walz et al for Predicting Prostate Cancer in a Man with a Serum PSA Less Than or Equal to 2.5 ng/mL

Vienna Nomogram for the Number of Prostate Core Biopsies

Prognostic Index of Shamash et al for Predicting the Response of a Patient with Castrate-Resistant Prostate Cancer to Dexamethasone and Diethylstilbesterol Therapy

Risk Categories of D'Amico et al for a Patient with Clinically Localized Prostate Cancer

Quantitative Gleason Score of Reese et al for Improving Prostate Cancer Risk Assessment

MRC 1993 Prognostic Factors for Metastatic Non-Seminomatous Testicular Germ Cell Tumors

The International Germ Cell Cancer Collaborative Group (IGCCCG) Classification of Metastatic Germ Cell Cancer

TNM Classification of Testicular Tumors

Prognostic Score of Beyer et al for a Patient with Metastatic Germ Cell Tumor Treated By High Dose Chemotherapy and Hematopoietic Progenitor Cell Support

Criteria for Response to Therapy in a Patient with a Germ Cell Tumor

Indiana University Staging System for Testicular Cancer

The Royal Marsden Hospital Classification for Testicular Cancer

The Memorial Sloan-Kettering Mathematical Model for Risk in Patients with a Germ Cell Tumor

Criteria of the German Testicular Cancer Study Group for Tumor Enucleation with Testicular Preservation in a Patient with Testicular Cancer

Criteria of Browne et al for Intertubular Growth in a Pure Seminoma

Prognostic Factors of Warde et al for Relapse in Stage I Seminoma Managed by Surveillance

Pathologic Features of Balzer and Ulbright for Spontaneous Regression of a Testicular Germ Cell Tumor

Prognostic Score of Einhorn et al for a Patient with a Metastatic Germ Cell Tumor

Choriocarcinoma Syndrome in a Patient with Metastatic Nonseminomatous Germ Cell Tumor

Growing Teratoma Syndrome (GTS)

Equation of Steyerberg et al for Predicting Necrosis at Resection of Residual Masses of a Metastatic Nonseminomatous Germ Cell Tumor (NSGCT) After Chemotherapy

Late Relapse of a Germ Cell Tumor

Score of the International Prognostic Factors Study Group for a Patient with a Metastatic Germ Cell Tumor Who Has Failed First-Line Cisplatin-Based Chemotherapy

Prognostic Factors of Fossa et al for a Patient with Testicular Cancer

TNM Classification and Staging of Penile Carcinoma

Risk of Disease Progression in Patients with Penile Squamous Cell Carcinoma Based on the Depth of Invasion and Vascular Invasion

Risk Factors of Ficarra et al for Metastases to Nonpalpable Inguinal Lymph Nodes in a Patient with Squamous Cell Carcinoma of the Penis

Prognostic Index (PI) of Cahilla et al for Predicting Metastases to Lymph Nodes in Squamous Cell Carcinoma of the Penis

Nomogram of Kattan et al for Predicting Survival After Amputation for Penile Carcinoma Based on Clinical Stage and Pathologic Findings

Nomogram of Kattan et al for Predicting Survival After Amputation for Penile Carcinoma Based on Pathologic Findings

Classification of Jackson for Carcinoma of the Penis

Prognostic Factors of Soria et al for a Patient with a Squamous Cell Carcinoma of the Penis

Model of Thuret et al for Predicting Cancer-Specific Mortality (CSM) for a Male with Penile Cancer

Scores of Taylor et al for Death and for Progression in Osteosarcoma

Tumor Necrosis After Preoperative Chemotherapy in Osteosarcoma

Enneking System for Staging Musculoskeletal Sarcomas

TNM Staging of Osseous Malignant Neoplasms

Grading Bone Tumors Based on Bone Destruction Pattern Seen on Radiographs

Prognostic Factors in Osteosarcoma

Histologic Grading Criteria of Evans et al for Conventional Chondrosarcoma of Bone

Risk Factors of Fiorenza et al for a Patient with a Chondrosarcoma of Bone

Grading Scheme of Tomita et al for Extension of a Sacral Osteosarcoma

Classification Scheme of Tomita et al for Vertebral Tumors

Model of Ferrari et al for Predicting Survival After Relapse With Lung Metastases in Osteosarcoma of the Extremities

Criteria of Malawer for Limb-Sparing Resection of a Bone Tumor in an Extremity

Histologic Grades of Gonzalez-Crussi et al for Sacrococcygeal Teratomas

Prognostic Factors of Mialou et al for Pediatric Patients with Metastatic Osteosarcoma

Prognostic Factors of Bacci et al for an Osteosarcoma of an Extremity Treated with Neoadjuvant Chemotherapy

Risk Factors and Clinical Features for a Malignant Bone Tumor in a Patient with Paget's Disease of Bone

Prognostic Factors of Longhi et al for an Elderly Patient with Osteosarcoma

Surgical Classification of Malawer et al for a Shoulder-Girdle Resection of a Bone Tumor

Dedifferentiation of a Chondrosarcoma

Classification System of Malawer et al for Shoulder-Girdle Resection in a Patient with Sarcoma

Histologic Grading Soft Tissue Sarcomas

AJCC TNM Staging of Soft Tissue Sarcomas

TNM Classification and Staging of Pediatric Soft Tissue Sarcomas

Criteria of Bergh et al for Low and High Risk Groups in Patients with Synovial Sarcoma

Prognostic Factors for Primary Localized Synovial Sarcomas of the Extremity

Prognostic Model of Rooser et al for Patients with Soft Tissue Sarcoma

Post-Operative Nomogram of Kattan et al for Predicting the Probability of Sarcoma-Specific Death at 12 Years After Surgery

Prognostic Factors of Le Doussal et al for Localized Primary Malignant Fibrous Histiocytoma (MFH)

Dutch and Memorial Sloan-Kettering Cancer Center Classification System for Retroperitoneal Soft Tissue Sarcoma

The Histopathologic Grading System of the French Federation of Cancer Centers (FNCLCC) for Adult Soft Tissue Sarcoma

Prognostic Staging System of Salo et al for a Malignant Fibrous Histiocytoma of an Extremity

Prognostic Factors of Kilpatrick et al for Myxoid and Round Cell Liposarcomas

Prognostic Factors of Behranwala et al for a Soft Tissue Sarcoma of the Buttock

Prognostic Nomogram of Dalal et al for a Patient with a Primary Liposarcoma

Prognostic Factors of Fiore et al for Myxoid, Round Cell and Pleomorphic Liposarcomas

MRI Findings of Tateishi et al Associated with the Grade of a Myxoid-Round Cell Liposarcoma

Classic Features of a Spindle Cell or Pleomorphic Lipoma

Prognostic Factors of Palmerini et al for a Patient with a Synovial Sarcoma

Using MDM2 and CPM Copy Numbers to Identify a Well-Differentiated Liposarcoma or Atypical Lipomatous Tumor

Histologic Features of Canter et al for Predicting Survival in a Patient with a Soft Tissue Sarcoma

Nomogram of Ardoino et al for Predicting Survival for a Patient with a Retroperitoneal Soft Tissue Sarcoma

Grading System of Khoury et al for Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas

Grading System of Parham et al for Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas (Pediatric Oncology Group Grading System for NRSTS)

Benign Lesions That May Be Misdiagnosed as a Well-Differentiated Liposarcoma

Criteria for a Lipoblast in the Diagnosis of Liposarcoma

Prognostic Factors of Salas et al for a Desmoid Tumor

Classification of Folpe and Weiss for an Ossifying Fibromyxoid Tumor (OFMT)

Predictors of Abbott et al for Sarcoma-Specific Survival in a Patient with a Primary Retroperitoneal Sarcoma

Risk Assessment Model of Demicco et al for a Patient with a Solitary Fibrous Tumor (SFT)

Staging of Classic Kaposi's Sarcoma (Non-AIDS Associated)

Staging of AIDS-Related Kaposi's Sarcoma

Histologic Features Associated with Malignancy in Hemangiopericytoma

Histologic Grades of Tang et al for Hemangiopericytoma of Bone

Criteria of Folpe et al for Malignancy in a Glomus Tumor

Prognostic Index of Stebbing et al for AIDS-Associated Kaposi's Sarcoma

Clinical and Pathologic Features of a Splenic Angiosarcoma

Risk Factors for Hepatic Angiosarcoma

Prognostic Score of Naka et al for a Patient with an Angiosarcoma

Criteria of Mena et al for an Anaplastic Hemangiopericytoma of the Central Nervous System

Head-Tilt Test for a Cutaneous Vascular Neoplasm of the Head and Neck

Clinical Features of Lymphangioleiomyomatosis (LAM)

Diagnostic Critera of the European Respiratory Society (ERS) for Lymphangioleiomyomatosis

Immunostaining for Human Herpesvirus 8 Latent Nuclear Antigen-1 (HHV-8 LNA-1) in the Diagnosis of Kaposi Sarcoma

Pyogenic Granuloma-Like Kaposi Sarcoma

Clinical Types of Kaposi Sarcoma (KS)

Sites of Clinical Lesions in Endemic (African) Kaposi Sarcoma

Rhabdomyosarcoma Score in Embryonal Rhabdomyosarcoma

Prognostic Factors in Rhabdomyosarcoma

Clinical Grouping Classification for Rhabdomyosarcoma

Prognostic Factors of Carli et al for Children with Metastatic Rhabdomyosarcoma

Failure Patterns in Rhabdomyosarcoma

Prognostic Factors of Oberlin et al for a Patient with Metastatic Rhabdomyosarcoma

Nomogram of Chisholm et al for Evaluating a Patient with Rhabdomyosarcoma in Relapse

Diagnosis of Neurofibromatosis Type 1

Clinical Risk Factors of Khosrotehrani for Mortality in Patients with Neurofibromatosis Type 1

Prognostic Factors of Carli et al for Pediatric Malignant Peripheral Nerve Sheath Tumor (MPNST)

Risk Factors of Needle et al for Progression of a Plexiform Neurofibroma

Classification of Samii et al for a Jugular Foramen Schwannoma

Elephantiasis Neuromatosa in Neurofibromatosis Type 1

Clinical Stages of Jugulotympanic Paraganglioma (Glomus Jugulare Tumor)

Pheochromocytoma of the Adrenal Gland Scaled Score (PASS)

Prognostic Factors in Pelvic Ewing Sarcoma

Prognostic Factors of Bacci et al for a Patient with Nonmetastatic Ewing Sarcoma of Bone Treated by Surgery and Adjuvant Chemotherapy

Prognostic Factors of Rodriguez-Galindo et al for a Patient with Ewing Sarcoma (St. Jude Children's Research Hospital Risk Stratification Scheme)

Prognostic Factors of Cotterill et al for a Patient with Ewing’s Sarcoma of Bone

Prognostic Factors of Leavey et al for a Patient with Ewing Sarcoma at First Recurrence Following Multimodality Therapy

Original and Modified Joshi Histologic Grading Criteria for Neuroblastomas

TNM Classification of Neuroblastoma

Clinical Staging of Neuroblastoma in Children Proposed By the Children's Cancer Study Group A

Genetic Types of Neuroblastoma from Brodeur et al

Prognostic Factors in Neuroblastoma

Surgical Risk Factors (SRF) of Cecchetto et al in a Child with a Neuroblastoma

Histologic Grading of Meningiomas

Prediction of Poor Prognosis for Patients with Meningiomas

Tumor Severity Score of Ziai to Describe Radiologic Features of a Brain Tumor

Criteria of Ho for Anaplastic Ependymoma

Prognostic Score of Pignatti et al for an Adult with a Low Grade Cerebral Glioma

Prognostic Factors of Wong et al for a Patient with a High Grade Cerebral Glioma

Response Criteria of Wong et al After Therapy for a High Grade Cerebral Glioma

Prognostic Classes of Sarkaria et al for High Grade Malignant Gliomas

Prognostic Score of Maillo et al for Patients with Meningioma

Criteria of Ho et al for Predicting Recurrence of a Meningioma Based on Histopathology and the MIB-1 Labeling Index

Prognostic Score of Salmon et al for an Adult with an Astrocytic Tumor

Criteria of Eberhart et al for Describing the Histopathologic Features of a Medulloblastoma

Staging Criteria of Chang et al for Medulloblastoma

Prognostic Factors of Zeltzer et al in Patients Undergoing Therapy for Medulloblastoma

Grades of Simpson for the Resection of a Meningioma Based on the Descriptions of Cairns et al

Risk Factors of Ayerbe et al for Recurrence Following Resection of an Intracranial Meningioma

Scoring System of Ayerbe et al for the Histologic Grading of a Meningioma

Response Criteria of MacDonald et al Following Therapy for a Malignant Glioma

Histologic Grading Criteria of Daumas-Duport et al for an Astrocytoma

Histologic Grading Criteria of Burger and Vogel for an Astrocytoma

Histologic Grading Criteria of Nelson et al for an Astrocytoma

Model of Novotny et al for Predicting the Probability of Intracranial Edema Following Gamma Knife Surgery on a Meningioma

Criteria of Taal et al for True vs Pseudo Progression Following Treatment of a Malignant Glioma

Indications to Refer a Pediatric Patient for Assessment of a Possible Brain Tumor

Risk Groups of Ellison et al for Childhood Medulloblastoma

Classification of Pituitary Adenomas on Imaging Studies

Indications for Surgical Resection of a Pituitary Adenoma

Clinical Features of a Craniopharyngioma

Risk Factors for Incomplete Resection of a Craniopharyngioma

Factors of Roelfsema et al for Evaluating a Patient Following Surgery on a Pituitary Adenoma

Predicting Growth of Small Choroidal Melanocytic Tumors Using the Risk Factors of Shields et al

Classification of Reese and Ellsworth for Ocular Retinoblastoma

Classification of the Childrens Cancer Group (CCG) for Extraocular Retinoblastoma

Staging System of St. Jude Children's Research Hospital for Retinoblastoma

Extraocular Tumors in a Patient with an RB1 Mutation (Secondary or Second Primary Tumors in Retinoblastoma)

Regression Patterns in Ocular Retinoblastoma Following Radiation Therapy

Predictors of Kaiserman et al for Conversion of a Choroidal Nevus to an Ocular Melanoma (Including the Combined KI Index)

Risk Factors for Conjunctival Squamous Cell Carcinoma

Clinical Features of Conjunctival Squamous Cell Carcinoma

Prognostic Features of Khelfaoui et al for a Patient with Retinoblastoma

1997 TNM Classification and Staging of Skin Cancer

Risk Factors for Recurrence and Metastasis in Squamous Cell Carcinoma of the Skin

Risk Factors for Development of Squamous Cell Carcinoma of the Skin

Staging System for Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)

Criteria of Folpe et al for Malignant Proliferating Trichilemmal Tumors (PTT)

Recurrence Index Score of Rigel et al for Predicting Recurrent Basal Cell Carcinoma Following Mohs Surgery

Risk Factors of Clayman et al for Mortality Associated with a Squamous Cell Carcinoma of the Skin

Risk Factors of Veness et al for Lymph Node Metastases in a Patient with Cutaneous Squamous Cell Carcinoma of the Head and Neck

Prognostic Factors of Andrea et al for a Patient with a Merkel Cell Carcinoma

N1S3 Staging System of Forest et al for Cutaneous Squamous Cell Carcinom of the Head and Neck with Lymph Node Metastases

Risk Factors of Schwartz et al for a Positive Sentinel Lymph Node in a Patient with a Merkel Cell Carcinoma

Prognostic Model of Soong for Malignant Melanoma

Prognostic Model of Clark et al for Stage I Malignant Melanoma

Grading Scheme of Spatz et al for Spitz Tumors in Children

Predicting Mortality in Stage I Malignant Melanoma Using the Equations of Helfenstein et al

Individualized Prognosis and Recurrence Risk Scores of Cochran et al for Patients with Malignant Melanoma

Model of Vollmer et al for Predicting Pretest Probability of Metastatic Cutaneous Malignant Melanoma to Lymph Nodes

Distance for Surgical Margins During the Excision of an Intermediate Thickness Primary Cutaneous Malignant Melanomas

Prognostic Model of Schuchter et al for Predicting 10 Year Survival in Patients with Primary Melanoma

Prognostic Model of Vollmer and Seigler al for Predicting 5 Year Survival in Patients with Cutaneous Malignant Melanoma

The Revised AJCC TNM Staging System for Cutaneous Malignant Melanoma

Prediction Scheme of Gamel et al for Predicting Survival in a Patient with Cutaneous Malignant Melanoma

Prediction Scheme of Gamel et al for Predicting Conditional Probability of Cure at Followup in a Patient with Cutaneous Malignant Melanoma

Prognostic Tree of Gimotty et al for a Patient with a Thin Primary Cutaneous Malignant Melanoma

Risk Factors of Strouse et al for a Pediatric Patient with Malignant Melanoma

Stringent Ultrasonographic Criteria for Diagnosis of Regional Lymph Node Metastasis from a Malignant Melanoma

Recommended Margins for Wide Local Excision of a Primary Malignant Melanoma

CART Model of Kruper et al for Predicting Sentinel Lymph Node Metastases in a Patient with AJCC Stage I or II Malignant Melanoma

ABCDEF Rule of Levit et al for Detection of Subungual Melanoma

Risk Factors Contributing to a Delay in Diagnosis of a Subungual Melanoma

Risk for Melanocytic Proliferation and Malignant Melanoma Following Organ Transplantation, Chemotherapy or Immunosuppression

Prognostic Index of Day et al for Cutaneous Melanoma and the Modified Prognostic Index of Schmid-Wendtner et al

Prediction Model of Andtbacka et al for Metastatic Melanoma to a Nonsentinel Lymph Node in a Patient with Metastases to a Sentinel Lymph Node

Risk Stratification of Schmoeckel et al for a Patient with Malignant Melanoma

When to Refer a Pigmented Skin Lesion for Evaluation

Ultrasonographic Criteria of Voit et al for Evaluating a Regional Lymph Node in a Patient with Malignant Melanoma

Rotterdam Criteria for Classifying Metastases from a Malignant Melanoma in a Sentinel Lymph Node

Risk Factors Associated with a Delay in the Diagnosis of a Malignant Melanoma

N-SNORE Scoring System of Murali et al for Predicting Risk of Non-Sentinel Lymph Node Positivity for a Patient with Cutaneous Malignant Melanoma

Hannover-II Scoring System for Classifying a Sentinel Lymph Node from a Patient with Malignant Melanoma

Tumors Other Than Malignant Melanoma That May Contain Melanin Pigment

Intracranial Hemorrhage Associated with Intracranial Metastases from a Malignant Melanoma

Prognostic Factors in Sebaceous Carcinoma of the Eyelid

Primary Cutaneous Adenoid Cystic Carcinoma (PCACC)

Ultrastructural Length to Width Ratio of Microvilli in the Diagnosis of Mesothelioma

TNM Classification of Pleural Mesothelioma

Immunohistochemical Panels of Carella et al for Separating Epithelial Malignant Mesothelioma from Adenocarcinoma of the Lung

Prognostic Score of Curran et al for Pleural Mesothelioma Based on the European Organization for Research and Treatment of Cancer (EORTC) Clinical Trials (EORTC Prognostic Score, EPS)

Prognostic Groups of the Cancer and Leukemia Group B (CALGB) for Patients with Malignant Mesothelioma

Risk Factors from the Cancer and Leukemia Group B (CALGB) Associated with Poor Prognosis in Patients with Malignant Mesothelioma

Risk Factors of Metintas et al for Poor Prognosis in a Patient with Diffuse Malignant Pleural Mesothelioma

Prognostic Factors of Bottomley et al for a Patient with Malignant Mesothelioma

Immunohistochemical Panel of Abutaily et al for Distinguishing Malignant Mesothelioma and Pulmonary Adenocarcinoma

Prognostic Index of Francart et al Predicting Survival for a Patient with Malignant Mesothelioma

Histologic Features Distinguishing Mesothelioma from Atypical Mesothelial Hyperplasia

Criteria of Bloss et al for Primary Peritoneal Serous Carcinoma

Staging Peritoneal Carcinomatosis

Gliomatosis Peritonei in a Patient with a Ventriculoperitoneal Shunt (VPS)

Gliomatosis Peritonei in a Patient with a Teratoma

Clinical Findings in a Patient with Pseudomyxoma Peritonei (PMP, Mucinous Ascites)

Lesions That May Precede Pseudomyxoma Peritonei

Histologic Classification of Pseudomyxoma Peritonei (PMP)

Extent of Surgery Score (ESS) of Miner et al for a Patient with Pseudomyxoma Peritonei (PMP)

Clinical Features of Pseudomyxoma Retroperitonei

Changes of Pseudomyxoma Peritonei on Imaging Studies

Criteria of Stoll and Crissey for Associating Development of a Malignancy with Preceding Trauma

Diagnostic Criteria for Tuberous Sclerosis

Diagnostic Criteria for the Muir-Torre Syndrome

Clinical Features of Carney's Complex

Clinical Features of Multiple Endocrine Neoplasia Type 1 (MEN1)

Clinical Features of Multiple Endocrine Neoplasia Type 2A (MEN2A, Sipple Syndrome)

Risk Groups for Medullary Carcinoma of the Thyroid in the MEN2 Syndrome Based on RET Testing

Clinical Features of Multiple Endocrine Neoplasia Type 2B (MEN2B, MEN3)

Classic Criteria for the Li-Fraumeni Syndrome (LFS)

Criteria of Birch et al for a Li-Fraumeni Syndrome Like Family (LFL)

Criteria of Chompret et al for Li-Fraumeni Syndrome

Clinical Features of Von Hippel-Lindau Syndrome (VHL)

Subtypes of Von Hippel-Lindau Syndrome (VHL) Based on Tumor Predilection

Tubers and Other Intracranial Lesions of Tuberous Sclerosis Complex

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)

Use of Immunohistochemistry to Identify the Primary Site of Metastatic Adenocarcinoma as Colonic versus Ovarian in Women

Decision Tree to Distinguish Primary Ovarian Adenocarcinoma from Metastases to the Ovary from Colon or Breast

Classification Rules to Distinguish Primary Ovarian Adenocarcinoma from Metastases to the Ovary from Colon or Breast

Evaluating a Metastatic Carcinoma Using Immunohistochemical Stains for Cytokeratins 7 and 20

Peritoneal Cancer Index (PCI) for Quantitation of Abdominal and Pelvic Metastases on CT Scan

Predictive Factors of Bhattacharyya for Neoplasia and Malignancy in a Neck Mass

Grading Extent of Disease (EOD) of Metastatic Tumor Involving Bone

Evaluation of a Cancer Patient with Headache for Intracranial Metastases

Risk Factors of Hirabayashi et al Affecting Survival After Palliative Surgery for Spinal Metastases

Inflammatory Oncotaxis

Algorithm of Hamaoka et al for the Diagnosis of Metastatic Breast Cancer to Bone

Scoring System of van der Linden and the Dutch Bone Metastasis Study Group for Predicting Survival in Patients with Metastases to the Spinal Column

Prognostic Scoring System of Tokuhashi et al for Preoperative Evaluation of a Patient with Metastases to the Spine

Features of a Metastatic Poorly Differentiated Carcinoma from an Unknown Primary Site Potentially Responsive to Chemotherapy (Unrecognized Extragonadal Germ Cell Cancer Syndrome)

Prognostic CART Analysis of Hess et al Starting with Lymph Node Status for a Patient with a Metastatic Carcinoma from an Unknown Primary

Prognostic CART Analysis of Hess et al Starting with Liver Status for a Patient with a Metastatic Carcinoma from an Unknown Primary

Scoring System of Tomita et al for Metastases to the Vertebral Spine

Classification of Harrington for a Metastatic Periacetabular Fracture

Radiographic Appearance of Common Carcinomas Metastatic to Bone

Score of Mirels for Predicting the Risk of Pathologic Fracture in a Bony Metastasis

Evaluation of a Patient with a Metastasis to the Umbilicus (Sister Mary Joseph's Nodule)

Prognostic Score of Schindl et al for a Patient with Colorectal Cancer and Liver Metastases

Clinical Findings Associated with Poor Prognosis in a Patient with Neoplastic Meningitis (Meningeal Carcinomatosis)

Clinical Findings in a Patient with Neoplastic Meningitis (Meningeal Carcinomatosis)

Recursive Partitioning Dendogram of Hess et al for Predicting the Primary Organ Site for a Metastatic Adenocarcinoma

Prognostic Factors of Ogihara et al for a Patient with Lung Cancer Metastatic to the Spine

Clinical Factors of Hosono et al Affecting Prognosis in a Patient with Spinal Metastases

Prognostic Factors of Seve et al for a Patient with a Carcinoma of Unknown Primary Site

Risk Factors of Seve et al for Survival and for Receiving Chemotherapy in a Patient with a Metastatic Carcinoma from an Unknown Primary Site

Risk Factors for Malignant Pericardial Effusion

Score of Van der Linden et al for Predicting Pathologic Fracture of the Femur (Modified Mirels Score)

Prognostic Factors of D'Ambrosio and Agazzi for a Patient with a Brain Metastasis from an Unknown Primary

Prognostic Score of Mizumoto et al for a Patient with Vertebral Metastases Treated with Radiation Therapy

Criteria of Swenerton et al for Metastatic Breast Cancer to Bone and Response to Therapy

Criteria of Swenerton et al for Metastatic Breast Cancer to the Bone Marrow and Response to Therapy

Criteria of Swenerton et al for Metastatic Breast Cancer to the Pleura and Response to Therapy

Prognostic Factors of Bruna et al for a Patient with Leptomeningeal Carcinomatosis

Prognostic Factors of He et al for a Patient with Hepatocellular Carcinoma Metastatic to Bone

Prognostic Factors of Mollet et al for a Patient with Skin Metastases from a Lung Carcinoma

Clinical Features of a Subungual Metastasis

Prognostic Factors of Lagerwaard et al for a Patient with Brain Metastases

Prognostic Factors of Elias et al for a Patient with Peritoneal Carcinomatosis Associated with Colorectal Carcinoma

Metastases to the Spleen

Prognostic Factors of Jeong et al for a Patient Who Requires a Ureteric Stent for Malignant Ureteric Obstruction

Carcinocythemia (Carcinoma Cell Leukemia)

Graded Prognostic Assessment (GPA) of Sperduto et al for a Patient with Brain Metastases

RTOG Recursive Partitioning Analysis (RPA) of Gaspar et al for Patients with Brain Metastases

Prognostic Score of Le Scodan et al for a Woman with Breast Cancer Metastatic to the Brain

Score Index for Radiosurgery (SIR) of Weltman et al for a Patient with Brain Metastases

Prognostic Factors of Park et al for a Woman with Breast Cancer Metastatic to the Brain

Score of Rades et al for Evaluating a Patient with Brain Metastases Treated By Whole Brain Radiotherapy

Grading System of Ryu et al for Metastatic Epidural Compression About the Spinal Cord

Prognostic Factors of Shuch et al for a Patient with a Brain Metastasis from a Renal Cell Carcinoma

Extent of Pleural Carcinomatosis (EPC) Score of Rodriguez-Pandero and Lopez-Meijas

Adrenal Hemorrhage Secondary to Metastasis from a Lung Cancer

Algorithm of Brady et al for Identifying an Adrenal Metastasis in a Patient with Lung Cancer Based on PET/CT Findings

Use of the Graded Prognostic Assessment (GPA) for a Patient with Brain Metastases from Malignant Melanoma or Renal Cell Carcinoma

Use of the Graded Prognostic Assessment (GPA) for a Patient with Brain Metastases from a Breast Carcinoma

Spinal Instability Neoplastic Score (SINS)

Bone Scan Index (BSI) for Quantitation of Metastatic Tumor to Bone

Institut Curie Prognostic Scores for Meningeal Carcinomatosis in a Woman with Metastatic Breast Cancer

Differential Diagnosis of Cystic Metastases to the Brain

Doxorubicin Pharmacokinetic Models of Ratain et al Using Limited Serum Sampling

Estimating Carboplatin Clearance Using the Equation of Chatelut et al

UICC Criteria for Tumor Response Following Therapy

Grading Criteria of the Japan Society for Cancer Therapy for the Histopathologic Effect of Chemotherapy on a Solid Tumor

Dosage Reduction for an Infusion of Alkeran (Melphalan hydrochloride)

Dosage Reduction for Navelbine (Vinorelbine tartrate) for Hematologic and/or Hepatic Toxicity

World Health Organization (WHO) Criteria for Tumor Response to Therapy

Method of Warnke et al to Manage a Foul-Smelling Malignant Ulcer

Conversion Factors of Le Deley et al for Doses of Alkylating Agents

Conversion Factors of Le Deley et al for Doses of Anthracyclines

Conversion Factors of Le Deley et al for Doses of Platinum Compounds and Epipodophyllotoxins

Method of Loos et al for Fixed Dosing of Cisplatin Based on Body Surface Area

Pharmacokinetic Test Dose of Bocci et al to Detect a Patient at Risk for Excessive Toxicity Prior to 5-Fluorouracil Therapy

Method of Calvert et al for Dosing Carboplatin Based on Estimated Glomerular Filtration Rate (GFR)

Formula of Schmitt et al for Estimating Carboplatin Clearance

Formula of Thomas et al for Estimating Carboplatin Clearance

Dosage Adjustment of Raymond et al for Irinotecan for a Patient with Colon Cancer and Hepatic Dysfunction

Equations of Egorin et al for Calculating the Dose of Carboplatin Based on the Nadir Platelet Count

Selection Criteria of Sandler et al for the Use of Bevacizumab with Paclitaxel-Carboplatin in a Patient with Lung Cancer

Reasons Why a Patient with Lung Cancer May Not Respond to a Tyrosine Kinase Inhibitor (TKI) to Epidermal Growth Factor Receptor EGFR)

Criteria of Kong et al for Metabolic Response to Therapy Seen on a PET Scan

Prediction of Recurrence Following Hepatic Resection for Metastatic Colorectal Carcinoma Using the Clinical Score of Fong et al

Selection of Patients with Recurrent Abdominal or Pelvic Sarcoma for Reoperation Using CT Scan Findings

Selection of Patients with Mucinous Carcinomatosis of the Peritoneum for Reoperation Using CT Scan Findings

Prognostic Score of Nordlinger et al for Patients with Surgical Resection of Metastatic Colorectal Carcinoma to the Liver

Prognostic Score of Cady et al for Disease Free Survival After Hepatic Resection of Metastatic Colorectal Carcinoma

WHO Criteria for Response of Metastatic Bone Lesions to Therapy

UICC Criteria for Response of Metastatic Bone Lesions to Therapy

Criteria of Hamaoka et al for Response of Metastatic Bone Lesions to Therapy

Staging System of Minagawa et al for Evaluating a Patient with Liver Metastases from a Colorectal Cancer

Criteria of Putnam for Resection of Pulmonary Metastases

Prognostic Factors of Temeck et al for Reoperation to Resect Pulmonary Metastases in a Pediatric Patient with a Sarcoma

Predictors of Adam et al for Complete Pathologic Response of Colorectal Metastases in the Liver Following Preoperative Chemotherapy

Model of Iwatsuki et al for a Patient with Metastatic Colorectal Adenocarcinoma Undergoing Hepatic Resection (Pittsburgh Grades)

Prognostic Factors of Rades et al for a Woman with Metastatic Breast Cancer Causing Spinal Cord Compression That Is Treated with Radiotherapy

Monitoring the Response of a Patient with Colon Cancer Metastatic to the Liver Using Computer Tomographic (CT) Morphologic Groups

Intraluminal Stents in the Management of a Woman with Stage IV Ovarian Carcinoma

Predictors of Stephens et al for a Poor Outcome Following Pulmonary Metastasectomy in an Adult Patient with Sarcoma

Criteria of Galsky et al That Make a Patient with Metastatic Urothelial Carcinoma Unfit for Cisplatin-Based Chemotherapy

Preoperative Neutrophil to Lymphocyte Ratio and Other Predictors of Halazun et al for a Patient Undergoing Resection of Colorectal Metastases in the Liver

Completeness of Cytoreduction Score (CC) of Sugarbaker and Chang for Peritoneal Carcinomatosis

Palliative Prognostic Score for Staging Terminally Ill Cancer Patients

Palliative Prognostic Index for Predicting Survival of Terminally Ill Cancer Patients

Poor Prognosis Indicator of Bruera et al for Patients with Terminal Cancer

Survival in Patients with Terminal Cancer Using Karnofsky Score and Key Symptoms

Indicator of Morita et al for Predicting Survival in Terminal Cancer Patients

The San Diego Severity Index (SDSI) for Patients with Terminal Cancer

The Palliative Care Outcome Scale (POS)

The Good/Bad/Uncertain (GBU) Index of Sloan et al for Predicting Survival in Patients with Advanced Cancer

Prognostic Scores of Culine for Predicting Survival in Patients with Metastatic Carcinoma from an Unknown Primary Site

Clinical Predictors of Vigano et al for Survival in Patients with Advanced Malignancy

Model of Maltoni et al for Predicting Survival in a Patient with Terminal Cancer

Prognostic Model of van der Gaast for Predicting Survival in a Patient with an Undifferentiated Carcinoma of Unknown Primary Site

Prognostic Factors of Nathan et al for Survival in a Patient Requiring Surgery for a Pathologic Fracture

Survival Prediction Score (SPS) of Chow et al in a Patient Receiving Palliative Radiotherapy

Prognostic Factors of Gripp et al for Predicting Survival in a Terminally Ill Cancer Patient

Prognostic Score of Barbot et al for a Patient with an Advanced Solid Tumor

Models of Chow et al for Predicting Survival in a Patient with Advanced Cancer

Survival Model of Rades et al for a Patient Undergoing Radiotherapy for Metastatic Spinal Cord Compression

Prognostic Score of Arkenau et al for a Patient with a Malignant Neoplasm (Royal Marsden Hospital Prognostic Score)

Bedside Score of Penel et al for Predicting 90 Day Mortality for a Patient with Cancer from an Unknown Primary

Vitamin B12 to C-Reactive Protein (CRP) Ratio in a Patient with Advanced Cancer

Model of Chiang et al for Predicting the Risk of Death within 7 Days of Hospice Admission for a Patient with Terminal Cancer

Prognostic Score of Suh et al for Predicting Survival for a Patient with Terminal Cancer

Predictors of Soubeyran et al for Early Death of an Older Adult Starting Cancer Chemotherapy

Prognostic Models of Olmos et al for Phase I Clinical Trials in the European Drug Development Network (EDDN)

Predictive Factors of Wray et al for Survival of Less Than 1 Month for a Patient with Hepatocellular Carcinoma

Japanese Palliative Oncology Study Prognostic Index (JPOS-PI)

Model of Ramchandran et al for Predicting 30-Day Mortality for a Cancer Patient in the Hospital

Diagnosis Score of Lortholary et al for a Paraneoplastic Syndrome

Hypoglycemia in Hemangiopericytoma and Other Nonendocrine Tumors

Polycythemia (Erythrocytosis) Secondary to Erythropoietin Released from a Tumor

Features of Paraneoplastic Necrotizing Myopathy

Paraneoplastic Intestinal Pseudo-Obstruction

Tumor-Associated Leukocytosis

Tumor-Associated Thrombocytosis

General Features of a Paraneoplastic Syndrome Involving Ectopic Hormone Secretion

Processes That May Underly a Paraneoplastic Syndrome

Different Tumor Histologic Appearances in Two Biopsies from a Patient with Cancer

The Vanishing Cancer Phenomenon

Carney Triad (Gastric Stromal Sarcoma, Pulmonary Chondroma, Paraganglioma)

Prognostic Groups of Ang et al for Patients with Orophayrngeal Cancer Based on Human Papillomavirus (HPV), Smoking History and TNM Stage

Classification of Weinberger et al for a Patient with Oropharyngeal Squamous Cell Carcinoma Based on Molecular Markers for Human Papillomavirus (HPV)

Criteria of Mete and Asa for Vascular Invasion in a Follicular Carcinoma

Score of Buffet et al for Predicting Recurrence for a Patient with a Papillary Thyroid Microcarcinoma

Criteria of Buffet et al for Outcomes Following Therapy for a Papillary Thyroid Carcinoma

Criteria of Watanabe et al for Diagnosing Large Cell Neuroendocrine Carcinoma (LCNEC) of the Lung in a Biopsy Specimen

Differential Diagnosis of a Mediastinal Tumor Based on Its Location within the Mediastinum on Imaging Studies

Nomogram of Mazouni et al for Predicting Survival for a Woman with Breast Cancer

Immediate Breast Reconstruction Risk Assessment Score (IBRRAS) of Fischer et al

Human Epidermal Growth Factor Receptor 2 (HER2) Testing by In Situ Hybridization (ISH) Using a Dual Probe Assay: 2013 ASCO/CAP Clinical Practice Guideline

Human Epidermal Growth Factor Receptor 2 (HER2) Testing by Immunohistochemistry (IHC): 2013 ASCO/CAP Clinical Practice Guideline

Reasons to Repeat HER2 Testing in a Patient with Breast Cancer

Criteria of Vance et al for Genetic Heterogeneity (GH) in HER2 FISH Testing in Breast Cancer

Equation of Flanagan et al for Approximating the Oncotype™ Recurrence Score (Original Magee Score)

New Magee Equations for Predicting the Oncotype DX Recurrence Score for a Woman with Breast Cancer

Scoring System of Lee et al for Predicting Lymph Node Metastases in a Patient with a T1 Esophageal Adenocarcinoma

Criteria of Ushiku et al for Very Well-Differentiated Gastric Adenocarcinoma of the Intestinal Type

Nomogram of Han et al for Predicting Long-Term Survival Following D2 Gastrectomy for Gastric Carcinoma

Predictors of Chandrasinghe et al for Survival of a Patient with Rectal Carcinoma

Nodal Staging Score (NSS) of a Goenen et al for a Patient with Node-Negative Colon Cancer

Risk Factors of den Dulk et al for Adverse Outcomes in a Patient with Rectal Cancer Treated with an Abdominoperineal (AP) Resection

Percentage of Stroma Within a Colon Cancer and Prognosis (Tumor-Stromal Ratio, Carcinoma-Stromal Ratio)

Japanese Criteria for the Grading of a Renal Cell Carcinoma

Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP)

Nomogram of Galsky et al for Predicting Survival of a Patient with Advanced Urothelial Carcinoma

Criteria of Nielsen et al for the Histologic Classification of a Smooth Muscle Tumor of the Vulva

Hyperchromatic Crowded Groups (HCG) in Cytologic Preparations from a Patient with Endocervical Adenocarcinoma in Situ

Problems Associated with Morcellation of a Uterus with an Unexpected Malignancy

Model of AlHilli et al for Predicting Non-Home Discharge of a Woman with an Epithelial Ovarian Cancer Following Primary Surgery

Prognostic Nomogram of Lee et al for Predicting Overall Survival for a Woman with Platinum-Sensitive Recurrent Ovarian Cancer

Algorithm of Fisher et al for Managing a Patient with a Fatty Neoplasm

Nomogram of Gronchi et al for Predicting Survival of a Patient with a Retroperitoneal Soft Tissue Sarcoma

Staging Protocol of Weiss et al for Pediatric Rhabdomyosarcoma

Fusion of PAX-FOXO1 Genes in Rhabdomyosarcoma (RMS)

O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity and Response of a Glioblastoma to Temozolomide Therapy

Modified RPA Prognostic Model of Li et al for a Patient with Glioblastoma Multiforme

Prognostic Factors of Daniels et al for an Adult with a Low-Grade Glioma

Placenta-Like Alkaline Phosphatase (PLAP) Associated with a Primary Intracranial Germinoma

Features of Baxter et al of a High-Risk Basal Cell Carcinoma on the Face

Indications for Mohs Surgery to Resect a Basal Cell Carcinoma on the Face

Atypical Fibroxanthoma

Brigham and Women's Hospital (BWH) Staging System for Cutaneous Squamous Cell Carcinoma

2009 UICC Staging System for Cutaneous Squamous Cell Carcinoma

2010 AJCC Staging System for Cutaneous Squamous Cell Carcinoma

Staging Classification of Falch et al for Anorectal Malignant Melanoma (ARMM)

Clark Levels for Cutaneous Malignant Melanoma

Perianal Mucinous Adenocarcinoma Associated with a Chronic Anorectal Fistula

Predictive Factors of Aaldriks et al for Deterioration of a Geriatric Patient Starting Chemotherapy

Prognostic Factors of Naito et al for a Patient with Metastatic Renal Cell Carcinoma Following Removal of Metastases

Prognostic Factors of Suh and Ahn for a Patient with Terminal Cancer

Prognostic Score of Suh and Ahn for a Patient with Terminal Cancer

Predictors of Partl et al for the Length of Survival for a Patient with Advanced Intra- and Extracranial Metastases from Malignant Melanoma

Prognostic Factors of Shin et al for a Terminally-Ill Cancer Patient

Neoplastic Fever (Cancer-Related Fever)

Risk Factors of Deganello et al for Multiple Malignancies of the Head and Neck

Yonsei Estimated Value (YEV) of Jeong et al for Predicting the Risk of a Lateral Neck Lymph Node Metastasis from a Papillary Thyroid Carcinoma

LU-RADS (Lung Reporting and Data System) for Computed Tomography Screening

Model of Liang et al for Predicting Survival of a Patient in China with a Resected Non-Small-Cell Lung Carcinoma (NSCLC)

Molecular Classification of Zhang et al for Infiltrating Ductal Carcinoma Based on Immunohistochemical Staining

Using Immunohistochemistry to Distinguish Between Usual and Atypical Ductal Hyperplasia of the Breast

Prognostic Factors of Dawood et al for a Woman with an Inflammatory Carcinoma of the Breast

Grading Criteria of Davison et al for a Mucinous Neoplasm of the Appendix

High Risk Locations for Radiofrequency (RF) Ablation of an Hepatocellular Carcinoma (HCC)

ALBI (Albumin-Bilirubin) Grade in a Patient with Hepatocellular Carcinoma

Nomogram of Wang et al for Survival After Adjuvant Radiotherapy in a Patient with Gallbladder Cancer

Nomogram of Wang et al for Survival Without Adjuvant Radiotherapy in a Patient with Gallbladder Cancer

National Comprehensive Cancer Network (NCCN) Criteria for Resectability of a Pancreatic Cancer

Carcinoid Crisis

Lin-Weiss-Bisceglia (LWB) Criteria for Evaluating an Adrenocortical Oncocytic Tumor

Contraindications for the Use of Bacillus Calmette-Guerin/Connaught (BCG) Therapy in a Patient with Urothelial Carcinoma of the Urinary Bladder

Criteria of the IBCG for Progression in Nonmuscle Invasive Bladder Cancer

Pelvic Masses Score (PMS) of Rossi et al for Evaluating a Pelvic Mass in a Woman

Luteinized Thecomatosis of the Ovary Associated with Sclerosing Peritonitis

Intratumoral Hemorrhage in a Vestibular Schwannoma (Acoustic Apoplexy)

Sites Where Ectopic Pituitary Adenomas Can Occur

Criteria of Lattes and Kessler for Metastasizing Basal Cell Carcinoma

AEIOU Features of Heath et al for Diagnosing a Merkel Cell Carcinoma

Nomogram of Maurichi et al for Predicting Survival of a Patient with a Thin Melanoma

Regression in a Melanoma

Simplified Peritoneal Cancer Index (SPCI) of the Netherlands Cancer Institute

7 Region Count for Peritoneal Cancer of the Netherlands Cancer Institute

Familial Atypical Multiple Mole Melanoma (FAMMM)-Pancreatic Carcinoma Syndrome Associated with CDKN2A

Risk Factors for Needle Track Seeding Following Needle Biopsy of a Hepatocellular Carcinoma

Drop Metastasis

Carcinoma Erysipeloides (Cutaneous Intralymphatic Metastases, Inflammatory Carcinoma, Metastatic Pseudocellulitis)

Terminology of Metastases within Small Dermal Vessels (Carcinoma Erysipelatoides, Carcinoma Telangiectoides, Carcinoma Hemorrhagiectoides)

Criteria for Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma (HCC)

Reasons Why a Tumor May Be Resistant to an Alkylating Agent

Levels of a Neck Dissection

Radical and Modified Radical Neck Dissection (RND and MRND)

Selective Neck Dissection (SND)

Clinical Findings of Hui et al for Impending Death in a Patient with Advanced Cancer

Revised Risk Classification of Frazier et al for Pediatric Extracranial Germ Cell Tumor

Criteria for a Pathological Lymph Node on Ultrasonography

Differential Diagnosis of a False Negative Biopsy of a Tumor

Pathologic Features Distinguishing Primary from Metastatic Tumor

Predictive Model of Guo et al for a Patient with Nasopharyngeal Carcinoma

Nomogram of Zhang et al for Predicting Postoperative Recurrence in a Patient with Stage Ia Non-Small Cell Lung Carcinoma (NSCLC)

PET/CT Volumetric Prognostic (PVP) Index of Zhang et al for a Patient with a Non-Small Cell Lung Cancer

Pittsburgh Predictor of Wilson and Weissfeld for Lung Cancer Detection in a Screening Program

Issues Associated with the Decision to Request a Contralateral Prophylactic Mastectomy (CPM)

Predictors of Goldflam et al for Significant Histologic Findings in a Contralateral Prophylactic Mastectomy

Nomogram of Albert et al for Predicting the Benefit of Radiation Therapy in an Older Woman with Breast Cancer After Conservative Surgical Resection

Score of Halevy et al for Determining the Need for Relumpectomy in a Woman with Invasive Breast Cancer

Aberrant Immunohistochemical Staining for CK7, CK20 and CDX2 in BRAF-Positive Colorectal Adenocarcinomas

Total Mesorectal Excision (TME) Score of Quirke et al

PDGFRA-Mutant Syndrome of Familial Gastrointestinal Stromal Tumors (GIST)

Hepatoma Arterial-Embolisation Prognostic (HAP) Score of Kadalayil et al Predicting the Prognosis of a Patient with a Hepatocellular Carcinoma Treated with Transarterial Embolisation (TAE)

Vienna Survival Model of Schoeniger-Hekele et al for Hepatocellular Carcinoma (VISUM-HCC)

Nomogram of Agopian et al for Predicting Recurrence of Hepatocellular Carcinoma Following Liver Transplant

Score of Wang et al for Predicting Recurrence of HBV-Associated Hepatocellular Carcinoma Following Liver Transplantation

Neutrophil-to-Lymphocyte and Platelet-to_Lymphocyte Ratios for Predicting Outcome Following Transplant for Hepatocellular Carcinoma

Paraneoplastic Syndromes Associated with Hepatocellular Carcinoma

Prognostic Factors of Qu et al for a Patient with Hepatocellular Carcinoma

Glypican-3 and Other Prognostic Factors of Shirakawa et al for a Patient with Hepatocellular Carcinoma

Nomograms of Li et al for Survival After Resection of a Huge Hepatocellular Carcinoma: Preoperative Model

Nomograms of Li et al for Survival After Resection of a Huge Hepatocellular Carcinoma: Postoperative Model

Score of Heath et al for Cytologic Differentiation of Adenocarcinoma from Reactive Atypia in Bile Duct Brushings

Algorithm of the International Association of Pancreatology (IAP) for Managing a Branch Duct Intraductal Papillary Mucinous Neoplasm (IPMN)

Paraneoplastic Syndromes Associated with Renal Cell Carcinoma

Clinical Findings in a Patient with Renal Cell Carcinoma

Examination of the Renal Sinus in a Patient with Renal Cell Carcinoma

Collins’s Law for Recurrence of Wilms Tumor and Other “Embryonic” Tumors (Collins Risk Period, CRP)

Nomograms of Rose et al for Locally Advanced Cervical Cancer: 5-Year Overall Survival

Nomograms of Rose et al for Locally Advanced Cervical Cancer: Prediction of Pelvic Recurrence

Nomograms of Rose et al for Locally Advanced Cervical Cancer: Prediction of 2-Year Progression-Free Survival (PFS)

Nomogram of Bendifallah et al for Predicting the Recurrence Risk for a Borderline Ovarian Tumor

Criteria of Zargar-Shoshtari et al for Pelvic Lymph Node Dissection in a Patient with Penile Cancer

Prognostic Factors Affecting Overall Survival in a Patient with Synovial Sarcoma (SS)

Indications of Clay et al for MDM2 FISH Testing of a Lipomatous Tumor

Madelung Disease (Multiple Symmetrical Unencapsulated Fat Deposits, Multiple Symmetrical Lipomatosis)

CT Scoring System of Middleton et al for Desmoid Precursor Lesions in a Patient with Familial Adenomatous Polyposis

Anatomic Classification of Benn et al for Pheochromocytoma and Paraganglioma

Tumors Positive for Ewing Sarcoma Breakpoint Region 1 (EWSR1) Translocation

Preoperative Prognostic Factors of Liang et al for a Patient with Glioblastoma Multiforme

Prognostic Factors of Donato et al for a Patient with Glioblastoma Multiforme

Prognostic Subclassification of Lyth for T1 Cutaneous Malignant Melanoma

Risk Factors of Lam et al for Malignant Melanoma Occuring in a Patient with a History of CLL or SLL

Placental Metastases

Pseudomyxoma Cutis

Prognostic Scores of Feldman et al for Men with Germ Cell Tumor Metastatic to the Brain: Score for Brain Metastasis Present at the Time of Initial Presentation

Prognostic Scores of Feldman et al for Men with Germ Cell Tumor Metastatic to the Brain: Score for Brain Metastasis Present at Relapse

Simplified Adjuvant Therapy Omission Risk Score of Datta et al for a Patient Following Resection of a Gastric Cancer

Model of Sasaki et al for Predicting 5-Year Survival Following Resection of Hepatic Metastases from a Colorectal Adenocarcinoma

Preoperative Prognostic Score of Malik et al for a Patient Undergoing Resection of Colorectal Liver Metastases

Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Systemic Chemotherapy

Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Surgery or Stereotactic Radiosurgery

Recommendations of Lin and DeAngelis for Treatment of Brain Metastases: Whole Brain Radiation Therapy (WBRT)

Stauffer Syndrome (Paraneoplastic Cholestasis or Hepatic Dysfunction)

TNM Classification and Clinical Staging of Breast Carcinoma from the 7th Edition of the AJCC

Nomograms of Van Zee et al for Predicting Additional Nodal Metastases in a Breast Cancer Patient with a Positive Sentinel Lymph Node: Without Frozen Section

Nomograms of Van Zee et al for Predicting Additional Nodal Metastases in a Breast Cancer Patient with a Positive Sentinel Lymph Node: With Frozen Section

Differential Diagnosis of Signet Ring Cells in a Histologic Section

Staging System of Dahlstrom et al for a Patient with HPV-Related Oropharyngeal Cancer

HPV-Related Pure and Mixed Neuroendocrine Carcinomas of the Oropharynx

Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Distant Metastasis-Free Survival (DMFS)

Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Disease-Specific Survival (DSS)

Prognostic Models of Zeng et al for a Patient with a Nasopharyngeal Carcinoma: Model for Local Recurrence-Free Survival (LRFS)

Risk Factors of Dedivitis et al for Pharyngocutaneous Fistula (PCF) After Total Laryngectomy

Nomogram of Lang et al for Predicting 10-Year Disease-Specific Death in a Patient with Papillary Thyroid Carcinoma

Nomogram of Lang et al for Predicting 10-Year Disease Recurrence in a Patient with Papillary Thyroid Carcinoma

Predictive Factors of Petric et al for Malignancy in a Follicular Neoplasm of the Thyroid

Monitoring a Patient for Recurrent Thyroid Cancer with Thyroglobulin and Other Monitoring a Patient with Thyroid Cancer for Recurrent Disease Using Thyroglobulin and Other Markers

Model of Evison et al for Predicting Malignancy in Lymph Nodes Diagnosed as Negative on EBUS-TBNA

Prognostic Score of Zhu et al for a Patient with Non-Small Cell Lung Carcinoma (NSCLC) Based on the Systemic Inflammatory Response (SIR)

Superior Mediastinum Syndrome (SMS)

Clinical Signs and Symptoms Which May Indicate the Presence of a Cardiac Tumor

Familial Atrial Myxoma Syndrome

Clinical and Laboratory Findings Associated with an Atrial Myxoma

Ultrasonographic Features of an Atrial Myxoma

Risk Factors for Recurrent Atrial Myxoma

Clinical Findings Associated with a Papillary Fibroelastoma

Clinical Features of a Cardiac Rhabdomyoma

Clinical and Pathologic Features of a Cardiac Fibroma

Clinical and Pathologic Features of a Cardiac Angiosarcoma

University of Southern California/Van Nuys Prognostic Index for Ductal Carcinoma in Situ (DCIS) of the Breast

Prognostic Score of Smith et al for Ductal Carcinoma in Situ (DCIS) of the Breast

Typical and Atypical Symptoms of Koo et al in Women with Breast Cancer

Nomogram of Sudo et al for Predicting Distant Metastases After Multimodality Therapy for a Patient with Localized Esophageal Cancer

C-Reactive Protein (CRP) to Albumin Ratio and Prognosis in a Patient with Operable Squamous Cell Carcinoma of the Esophagus

Prognostic Score of Deans et al for a Patient with Gastro-Esophageal Cancer

Asia-Pacific Colorectal Screening (APCS) Score of Yeoh et al

Nomogram of Cheung et al for Identifying a Patient with Colon Cancer Who Is at Risk for Early Mortality

Score of Imperiale et al for Risk of Advanced Colorectal Neoplasia in an Asymptomatic Adult

Prognostic Factors of Harris et al Following Palliative Resection of a Colorectal Carcinoma

Metachronous Advanced Colorectal Neoplasm Prediction Scoring (MAPS) Model of Lee et al

Risk Factors of Park et al for Endoscopic Screening of a Patient for Advanced Proximal Colon Neoplasm

Prognostic Nomogram of Hsu et al for the Barcelona Clinic Liver Cancer System for a Patient with Hepatocellular Carcinoma

STATE Score of Hucke et al for a Patient with Hepatocellular Carcinoma

ART Score of Sieghart et al for a Patient with Hepatocellular Carcinoma

Up-to-Seven Criteria of Mazzaferro et al for Liver Transplantation in a Patient with Hepatocellular Carcinoma (HCC)

Risk Factors of D’Amico et al for Recurrent Hepatocellular Carcinoma Following Liver Transplant

Post-Resection Independent Predictive (PRIP) Score of Hung et al for Recurrence of Hepatocellular Carcinoma Associated with Hepatitis B Virus (HBV)

Criteria of Khorana et al and the American Society of Clinical Oncology (ASCO) for Potentially Curable Pancreatic Cancer

Preoperative Prognostic Score (PPS) of Miura et al for a Patient with Locally Advanced Pancreatic Body Cancer After Distal Pancreatectomy and Celiac Axis Resection (DP-CAR)

Prognostic Factors of Marulli et al for a Patient with a Primary Chest Wall Chondrosarcoma

Models of Wang et al for a Patient with an Extremity Osteosarcoma: Model for 5-Year Lung Metastasis Free Survival

Models of Wang et al for a Patient with an Extremity Osteosarcoma: Model for 5-Year Overall Survival

Prognostic Factors of Singer et al for a Patient with Retroperitoneal Liposarcoma

Clinical and Pathologic Findings in Dedifferentiated Liposarcoma

Criteria for Identifying a Malignant Granular Cell Tumor

Prognostic Factors of Wushou et al for a Head and Neck Hemangiopericytoma

Angioglioma

Recursive Partitioning Analysis (RPA) of Scott et al for a Patient >= 70 Years Old with Glioblastoma

Clinical Presentation of a Patient with Diffuse Intrinsic Pontine Gliome (DIPG)

Score of Jansen et al for Predicting 12-Month Mortality for a Child with a Diffuse Intrinsic Pontine Glioma (DIPG)

Risk Factors of Verlut et al for Poor Overall Survival for a Patient with Glioblastoma Multiforme Receiving Chemoradiotherapy

Clinical Features of an Intracranial Teratoma (Germinoma) Arising in the Suprasellar Region

MEL (Melanoma) Scoring System for PD-L1 Expression in Malignant Melanoma

Multiple Endocrine Neoplasia 4 (MEN4) Syndrome

Metastasis to a Percutaneous Endoscopic Gastrostomy (PEG) Site

Revised Prognostic Scoring System of Tokuhashi et al for Preoperative Evaluation of a Patient with Metastases to the Spine

Clinical Findings Associated with Metastatic Carcinoma to the Heart

Staging System of Nagashima et al for Metastatic Colorectal Carcinoma to the Liver

Factors of Chung et al Associated with Favorable Salvage Surgery of a Recurrent Squamous Cell Carcinoma of the Head and Neck

Score of Rades et al for Identifying a Patient with Metastatic Spinal Cord Compression with Short Life Expectancy

Staging System of Lee et al for M0 Oral Cancer

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Preoperative Endocrine Prognostic Index (PEPI) of Ellis et al for a Woman with Breast Cancer

Clinical Score of Oliphant et al Predicting Cancer-Specific Survival for a Patient with Stage II Colon Cancer

NSP Score of Zhang et al for Evaluating a Patient with Intermediate Stage Hepatocellular Carcinoma

MORAL Scores of Halazun et al for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplant

Predictors of Muszynska et al for Incidental Gallbladder Cancer in a Patient Undergoing Cholecystectomy for Benign Disease

Clinical Findings That May Indicate the Presence of Cholangiocarcinoma in a Patient with Hepatolithiasis

Clinical Score of Tran et al for Long-Term Survival After Repeat Resection of a Recurrent Adrenocortical Carcinoma

Predictors of Gershman et al for 1-Year Metastasis-Free Survival (MFS) Following Surgery for Renal Cell Carcinoma (RCC)

Predictors of Gershman et al for Mortality Following Surgery for Renal Cell Carcinoma (RCC)

Rajavithi-Ovarian Cancer Predictive Score (R-OPS) of Yanaranop et al

Classification of Craniopharyngioma on Sagittal MRI Imaging

Multimodality Prognostic Score (MMPS) of Opitz et al for a Patient with a Malignant Pleural Mesothelioma

Primary Pericardial Mesothelioma

Prognostic Score of Perri et al for a Woman with Metastatic Gynecologic Cancer and Malignant Bowel Obstruction

Late Chemotherapy

Indications of Cummins et al for Palliative Surgery in a Patient with Metastatic Colorectal Carcinoma

Prognostic Scale of Chuang et al for Survival in a Patient with Terminal Cancer in Taiwan

Chinese Prognostic Scale (ChPS) of Lingjun et al Predicting Survival in Chinese Patients with Advanced Cancer

Prognostic Factors of Bachelot et al for a Patient with Advanced Cancer in a Phase I Clinical Trial

Modified Palliative Prognostic Score of Scarpi et al with Addition of Delirium Assessment in a Patient with Terminal Cancer

Nomogram of Feliu et al for a Patient with Terminal Cancer

Palliative Prognostic Score of Kurashima et al for a Terminally-Ill Pediatric Patient with Cancer

Risk Model of Huang et al for Predicting Survival in a Patient with Carcinoma of Unknown Primary Site

Predictors of Wright et al for Survival in a Patient with Incurable Stage IV Cancer and Malignant Bowel Obstruction

Signs and Symptoms of Occult Malignancy

Score of Martinez-Gimeno et al for Predicting Lymph Node Metastases in a Patient with Squamous Cell Carcinoma of the Oral Cavity

Predictors of Bhattacharyya and Fried for Lymph Node Metastases from a Carcinoma or Sarcoma Arising in a Major Salivary Gland

Staging of an Anaplastic Thyroid Carcinoma According to the 8th Edition of the AJCC Staging Manual

Staging of a Differentiated Thyroid Carcinoma According to the 8th Edition of the AJCC Staging Manual

TNM Coding for a Thyroid Carcinoma from the 8th Edition of the American Joint Commission on Cancer (AJCC) Staging Manual

HAL Model of O'Connell et al for Prediction of Lymph Node Metastasis in Lung Cancer

Prognostic Factors of Toyokawa et al for a Patient with Resectable Thoracic Esophageal Squamous Cell Carcinoma

Product of Serum Alpha-Fetoprotein and PIVKA-II for Prediction of Aggressive Behavior in an Early Stage Hepatocellular Carcinoma (HCC)

T-Stage Classification of Jarnagin et al for Hilar Cholangiocarcinoma (Blumgart Preoperative Staging System for Hilar Cholangiocarcinoma)

Findings of Gaujoux and Mihai Associated with an Adrenocortical Adenocarcinoma in a Patient with an Adrenal Mass

Risk Factors of Gaujoux and Mihai for Recurrence of an Adrenocortical Adenocarcinoma After Surgery

Risk Factors of Haisma et al for Lymph Node Metastases in a Patient with a Squamous Cell Carcinoma of the Skin from the Head and Neck

Risk Factors of Asgari et al for Squamous Cell Carcinoma of the Skin in an HIV-Positive Patient with a History of Nonmelanoma Skin Cancer (NMSC)

Prognostic Factors for Anorectal Malignant Melanoma

Prognostic Factors of Sangisetty and Miner for a Patient with Malignant Ascites

Nomogram of Renfro et al for Predicting 90-Day Mortality for a Patient with Metastatic Colorectal Carcinoma

RULE of Scully for Early Recognition of Oral Cancer

Endobronchial Ultrasound (EBUS) Scoring System of Schmid-Bindert et al for Predicting Metastatic Cancer to Mediastinal Lymph Nodes

Histological Score and Classification Tree of McCallum et al for a Woman with Node-Negative Breast Cancer

Nomogram of Eom et al for Survival After Gastric Cancer Surgery

BALAD Score of Toyoda et al for Staging Hepatocellular Carcinoma

Conventional Japanese Integrated Staging (JIS, c-JIS) Staging System of Judo et al for a Patient with Hepatocellular Carcinoma

LCSGJ (Liver Cancer Study Group of Japan) TNM Classification for Hepatocellular Carcinoma

Biomarker-Combined Japanese Integrated Staging (bm-JIS) Staging System of Kitai et al for a Patient with Hepatocellular Carcinoma

GALAD Score of Johnson et et al for the Diagnosis of Hepatocellular Carcinoma

Hong Kong Staging Classification for Liver Cancer (HKLC) of Yau et al

Nomogram of Liu et al for Recurrence of an Early Hepatocellular Carcinoma After Radiofrequency Ablation (RFA)

Advanced Liver Cancer Prognostic System (ALCPS) of Yau at al

NIACE Score of Adhoute et al for Predicting Overall Survival in a Patient with Advanced Hepatocellular Carcinoma

Taipei Integrated Scoring (TIS) System of Hsu et al for a Patient with Hepatocellular Carcinoma

Total Tumor Volume (TTV) of the Taipei Integrated Scoring (TIS) of Hsu et al for a Patient with Hepatocellular Carcinoma

Sorafenib Advanced HCC Prognosis (SAP) Score of Edeline et al for a Patient with Advanced Hepatocellular Carcinoma

ABCR Score of Adhoute et al for a Patient with Hepatocellular Carcinoma

Prognostic Score of Tournoux-Facon et al for a Patient with Advanced Hepatocellular Carcinoma

CLIP Score Plus Performance Status for a Patient with Advanced Hepatocellular Carcinoma

BALAD-2 Score of Fox et et al for Determining Prognosis for a Patient with Hepatocellular Carcinoma

Modified Barcelona Clinic Liver Cancer (BCLC) System of Chan et al with Integration of the Albumin-Bilirubin (ALBI) Score for a Patient with Hepatocellular Carcinoma

Treatment Guidelines of the Asian Pacific Association for the Study of the Liver (APASL) for a Patient with Hepatocellular Carcinoma

Modified Hepatoma Arterial Embolization (mHAP) Score of Pinato et al for Predicting Survival for a Patient with Hepatocellular Carcinoma

Risk Factors of Trivedi et al for Hepatocellular Carcinoma Arising in a Patient with Primary Biliary Cholangitis (PBC)

2005 Japanese Treatment Algorithm for a Patient with Hepatocellular Carcinoma

Scoring System of Yang et al for Selecting a Patient with Hepatocellular Carcinoma for Living Donor Liver Transplantation

Classification of Shi et al for Malignant Thrombus in the Portal Vein Associated with Hepatocellular Carcinoma

Prognostic Score of Shen et al for a Patient with a Solitary Large Hepatocellular Carcinoma

Preoperative Risk Score of Sasaki et al for a Patient with Intrahepatic Cholangiocarcinoma

Extrarenal Wilms' Tumor (ERWT)

Prognostic Factors of Nathan et al for a Patient with a Primary Retroperitoneal Sarcoma

Classification of Shamblin et al for Carotid Body Tumor (CBT, Cervical Paraganglioma)

Clinical Findings Associated with a Carotid Body Tumor (CBT, Cervical Paraganglioma)

Risk Factors of Kim et al for Complications After Resection of a Carotid Body Tumor (CBT, Cervical Paraganglioma)

Clinical Features of a Vagal Paraganglioma (VP)

Diffuse Melanosis Cutis (DMC) Associated with Metastatic Malignant Melanoma

Predictive Model of Ohn et al for the Diagnosis of Subungual Melanoma in Situ

Metastatic Carcinoma to the Nasal Tip

LENT Score of Clive et al for Predicting the Prognosis of a Patient with a Malignant Pleural Effusion

Oswestry Spinal Risk Index (OSRI) of Balain et al

PROMISE Model of Psallidas et al for a Patient with Malignant Pleural Effusion: Clinical Score

PROMISE Model of Psallidas et al for a Patient with Malignant Pleural Effusion: Biochemical Score

Prognostic Factors of Yang et al for Postoperative Survival in a Patient with Spinal Metastases

Score of Bauer and Wedin for a Patient with Spinal and Extremity Metastases

Lymph Node Ratio (LNR)

PD-L1 Combined Positive Score (CPS)

Risk Factors of Kuo et al for Disease-Specific Mortality Associated with Medullary Carcinoma of the Thyroid Gland

Lung Cancer Arising in a Lung Transplant Recipient

Clinical Prediction Rule of Shafazand and Gould for Mediastinal Metastasis from a Non-Small Cell Lung Cancer (NSCLC)

Risk Factors of Visser et al for Invasive Breast Carcinoma Following Resection of an Ipsilateral Ductal Carcinoma in Situ (DCIS)

Nomogram of Lee et al for Gastric Cancer Associated with Peptic Ulcer Disease in Taiwan

eCura System of Hatta et al for Curability of Early Gastric Cancer After Endoscopic Submucosal Dissection

HCC-MELD Score of Freeman et al

Nomograms of Fu et al for a Patient with Hepatocellular Carcinoma and without Portal Vein Tumor Thrombosis After Curative Resection: Overall Survival

Nomograms of Fu et al for a Patient with Hepatocellular Carcinoma and without Portal Vein Tumor Thrombosis After Curative Resection: Recurrence-Free Survival (RFS)

Albumin to Alkaline Phosphatase Ratio in a Patient with Cholangiocarcinoma

Asbestos-Related Cholangiocarcinoma

Fibrinogen-to-Albumin Ratio (FAR) and Other Prognostic Factors of Xu et al for a Patient with Gallbladder Cancer

Prognostic Score of Schweitzer et al for a Biliary Tract Cancer

Risk Factors of Lazaryan et al Afffecting Overall Survival of a Patient with an Ampullary Adenocarcinoma

Nomograms of Cao et al for Predicting Survival of a Patient with a Gastric Neuroendocrine Carcinoma (NEC)

Nomogram of Kim et al for Recurrence-Free Survival (RFS) After Curative Resection of an Adrenocortical Carcinoma

Nomogram of Kim et al for Overall Survival (OS) After Curative Resection of an Adrenocortical Carcinoma

Adrenal Cortical Carcinoma Prognostic Score of Freire et al

Predictors of Sahovaler et al for Outcome in a Patient with Cutaneous Squamous Cell Carcinoma of the Head and Neck with Regional Lymph Node Metastases

Staging System of Breuninger et al for Cutaneous Squamous Cell Carcinoma

Visceral Crisis in Metastatic Cancer

Modified Bauer Score of Leithner et al for a Patient with a Spinal Metastasis

Prognostic Factors of Sioutos et al for a Patient with Spinal Metastases

ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)

Prognostic Index of Sundaresan et al for Identifying a Lung Cancer Patient with Multiple Brain Metastases Who May Have an Early Death and Not Benefit from Whole Brain Radiotherapy

Nuclear-to-Cytoplasmic Ratio (NCR)

Histopathologic Score of Nason et al for Squamous Cell Carcinoma of the Floor of the Mouth

Model of Cecatto et al for Pharyngocutaneous Fistula After Laryngectomy for Cancer

Prognostic Score of Silva-Figueroa et al for Parathyroid Carcinoma

Laboratory Prognostic Index of Ulas et al for a Patient with Non-Small Cell Lung Cancer (NSCLC)

Prognostic Index of Kasymjanova et al for a Patient with Stage IV Non-Small Cell Lung Cancer (NSCLC)

Clinical Prognostic Score of Gong et al for a Patient with Advanced Non-Small Cell Lung Cancer (NSCLC)

Prognostic Score of Trape et al for Advanced Non-Small Cell Lung Cancer (NSCLC)

Montreal Prognostic Score (MPS) of Gagnon et al for Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical Prediction Rule of Galvin et al for Female Breast Cancer

Histopathologic Prognostic Score of Zhu et al for Gastric Carcinoma

Recommendations for Continuing Surveillance of a Patient Diagnosed with Colon Cancer

Predictors of Dumont et al for a Positive Circumferential Margin Following Chemoradiotherapy and Sphincter-Sparing Surgery for a Low Rectal Cancer

Nomograms of Kawai et al for a Patient with Stage IV Colorectal Cancer After Curative Resection: Disease-Free Survival (DFS)

Nomograms of Kawai et al for a Patient with Stage IV Colorectal Cancer After Curative Resection: Overall Survival (OS)

Tumor Budding in Colorectal Carcinomas

Predictors of Yim et al for Lymph Node Metastases in a Patient with a T1 Colorectal Carcinoma Invading Into the Submucosa

CRC-PRO Calculator of Wells et al for Colorectal Cancer: Nomogram for Males

CRC-PRO Calculator of Wells et al for Colorectal Cancer: Nomogram for Females

Score of Maeyama et al for Narrow-Band Imaging of a Colorectal Carcinoma

Criteria of Sato et al for Venous Invasion in Colorectal Carcinoma

SNACOR Score of Kim et al for a Patient Undergoing Chemoembolization for Hepatocellular Carcinoma

Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma

Transarterial Chemoembolization (TACE) Resistance Individualized Prediction (TRIP) Score of Sciarra et al for Hepatocellular Carcinoma

Real-World Risk Score for Hepatocellular Carcinoma (RWS-HCC) of Poh et al

Prognostic Nomogram of Xu et al for a Transcatheter Arterial Chemoembolization (TACE) in a Patient with Unresectable Hepatocellular Carcinoma

VPEFR Risk Factors in Hepatoblastoma

Risk Stratification for Hepatoblastoma from the Children's Hepatic Tumors International Collaboration

Chiba HCC in Intermediate Prognostic (CHIP) Score of Ogasawara et al

Clinical Risk Score (CRS) of Zheng et al for Recurrence of an Hepatocellular Carcinoma

Mayo Staging System for Perihilar Cholangiocarcinoma

MEGNA Score of Raoof et al for Intrahepatic Cholangiocarcinoma

GI-NEC Score of Lamarca et al for High-Grade Gastrointestinal Neuroendocrine Carcinoma

Prognostic Instrument of Manig et al for a Patient Irradiated for Recurrent Bladder Cancer

Nomograms of Raut et al for Retroperitoneal Sarcoma: Disease-Free Survival (DFS)

Nomograms of Raut et al for Retroperitoneal Sarcoma: Overall Survival (OS)

Cytologic Features of Klijanienko et al Indicating a High Risk Neuroblastic Tumor

Mitosis-Karyorrhexis Index (MKI)

Heidelberg Prognostic Score for Recurrent Gliomas

Prognostic Factors of Scholtyssek et al for a Progressive High-Grade Glioma Undergoing Re-Irradiation

Squamous Cell Carcinoma Associated with Longstanding Hypertrophic Lichen Planus

Prognostic Factors of Pfannschmidt et al Following Resection of Pulmonary Metastases from a Renal Cell Carcinoma

Prediction Rule of Tello et al for Malignancy of a Hepatic Lesion Seen on MRI

Krukenberg Tumor of the Ovary

Staging System of Noura et al for Colorectal Cancer with Synchronous Peritoneal Metastases

Clinical Score of Konopke et al for Survival After Resection of Colorectal Liver Metastases

Prognostic Score of Nordlinger et al for Surgical Resection of Colorectal Carcinoma Metastases to the Liver

Basingstoke Models for Survival After Resection of Hepatic Metastases from a Colorectal Cancer: Preoperative Score

Basingstoke Models for Survival After Resection of Hepatic Metastases from a Colorectal Cancer: Postoperative Score

Prognostic Model of Lise et al for a Patient Having Resection of Hepatic Metastases from a Colorectal Carcinoma

Staging System of Ueno et al for a Patient with Hepatic Metastases from a Colorectal Carcinoma

Scoring System of Nagashima et al for a Patient with Hepatic Metastases from a Colorectal Carcinoma

Marrow Metastases Prognostic Score (MMPS) of Chou et al

Prognostic Score of Regierer et al for Metastatic Breast Cancer

Munich Score of Meimarakis et al for Predicting Long-Term Survival Following Resection of Pulmonary Metastases of a Renal Cell Carcinoma

Prognostic Factors of Lin et al for a Patient Undergoing Pulmonary Metastasectomy for Sarcoma

Palliative Care Screening Tool of Ostgathe et al for an Adult with Cancer

Triggers for Suspecting Cancer By a General Practitioner

HPV-Related Anogenital Carcinomas in Renal Transplant Recipients

Modified Glasgow Prognostic Score (mGPS) and Cancer Survival

Predictive Score of Lin et al for 90-Day Mortality for a Patient with Head and Neck Cancer Following Chemoradiation

Composite Pathologic Risk Stratification of Cramer et al for Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma

Staging System of Yueh et al for a Recurrent, Persistent or Second Primary Cancer of the Oral Cavity or Oropharynx

Risk Factors of Morton et al for a Pharyngocutaneous Fistula Following Laryngectomy

Histologic Features of Bondeson et al for a Parathyroid Carcinoma

Criteria for the Diagnosis of Pulmonary Adenocarcinoma in Situ

Criteria for the Diagnosis of Minimally Invasive Pulmonary Adenocarcinoma

Prognostic Factors of Kondo and Monden for Thymoma or Thymic Carcinoma

KiGE Index of Strand et al for a Woman with an N0 or N1 Breast Cancer

CAGE Model of Strand et al for Prognosis in a Woman with Breast Cancer

Model of Dingemans for Evaluating a Woman with Breast Cancer and a Positive Sentinel Lymph Node Biopsy

Dutch Prediction Tool of van den Hoven et al for Risk of Metastases to Non-Sentinel Axillary Lymph Nodes in a Woman with Breast Cancer and a Positive Sentinel Node

Nomogram of Shin et al for Predicting a Positive Resection Margin Following Breast-Conserving Surgery for Breast Cancer

Nomogram of Lian et al for the Diagnosis of Intraductal Breast Cancer Using Ductoscopy

Prediction Model of Meurs et al for Invasive Breast Cancer for a Woman with Ductal Carcinoma in Situ (DCIS) in a Breast Biopsy

Model of Zhang et al for Predicting Axillary Lymph Node Metastases in a Chinese Woman with Breast Cancer

Nomogram of Pleijhuis et al for Predicting Positive Surgical Margins at Breast-Conserving Surgery

Nomograms of Duan et al for Esophageal Squamous Cell Carcinoma: Disease-Free Survival

Nomograms of Duan et al for Esophageal Squamous Cell Carcinoma: Overall Survival

Preoperative Nomogram of Goense et al for a Patient with Esophageal Adenocarcinoma

Lymph Node Involvement in Carcinoma of the Esophagus

Issues of Buckley et al in the CT Staging of a Small Bowel Adenocarcinoma

Model of Backes et al for Predicting Metastases from a Pedunculated T1 Colorectal Carcinoma

Difficulty Scores of Ban et al for Laparoscopic Liver Resection n

Updated Barcelona Clinic Liver Cancer (BCLC) Staging Classification

LabScore of Tsilimigras et al for a Patient with Intrahepatic Cholangiocarcinoma

Nomogram of Groot Koerkamp et al for Survival After Resection of a Perihilar Cholangiocarcinoma (PHC)

Findings of Tirotta et al Distinguishing a Benign from Malignant Proximal Biliary Stricture

Preoperative Risk Score of Wiggers et al to Predict Occult Locally Advanced or Metastatic Perihilar Cholangiocarcinoma

T Stage Criteria of Burke et al for Hilar Cholangiocarcinoma

Japanese Society of Biliary Surgery (JSBS) Staging Classification for Gallbladder Cancer

Prognostic Model of Gerken et al for Resectability of a Malignancy in the Head of the Pancreas

Algorithm of Gerken et al for Managing a Patient with a Malignancy in the Head of the Pancreas

Ratio of Pancreatic Duct Caliber to Width of the Pancreas (PDG Ratio)

Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) Score of Klompmaker et al

Characteristics of Paniccia et al for a Patient Who Survives 10 Years with Pancreatic Ductal Adenocarcinoma

Nomogram of Huang et al for Predicting Survival of a Patient with Pancreatic Duct Adenocarcinoma

Nomogram of Tol et al for Evaluating a Patient with a Pancreatic or Periampullary Cancer

Use of Imaging Studies to Determine Resectability of a Pancreatic Adenocarcinoma

Nomograms of He et al for Survival of a Patient with Periampullary Adenocarcinoma: Overall Survival

Nomograms of He et al for Survival of a Patient with Periampullary Adenocarcinoma: Progression-Free Survival

Prognostic Factors of Yamaguchi et al for a Pancreatoduodenal Carcinoma

Clinical Features of Roggo et al for a Carcinoid Tumor of the Appendix

Prognostic Factors of Janson et al for a Carcinoid Tumor

Risk Factors of Burke et al for Metastases from a Carcinoid Tumor of the Duodenum

Prognostic Factors of Roy and Chetty for Goblet Cell Carcinoid Tumors of the Appendix

Prognostic Factors of Mekhail et al for Previously Untreated Metastatic Renal Cell Carcinoma

Prognostic Model of Motzer et al for a Patient Treated with Interferon-Alfa for Advanced Renal Cell Carcinoma

Prognostic Factors of Heng et al for a Patient with Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy

Prognostic Scores of Sylvester et al for a Ta or T1 Carcinoma of the Urinary Bladder

Preoperative Nomogram of Petros et al for Predicting Non-Organ Confined Urothelial Carcinoma

Prognostic Factors of Homesley et al for a Patient with Vulvar Carcinoma

Prognostic Factors of Perez et al for Squamous Cell Carcinoma of the Cervix Treated with Radiation Alone

Classification of Lapinska-Szumczyk et al for Endometrial Adenocarcinoma Using Estrogen Receptor, Progesterone Receptor and HER2

Risk Factors of Creasman et al for Lymph Node Metastases in a Woman with Endometrial Cancer

Metastatic Sites of Uterine Sarcoma

Nomogram of Godoy et al for Prediction of Lymph Node Involvement in a Male with a Prostate Cancer

Yonsei Nomogram of Kim et al to Predict Lymph Node Invasion in an Asian Male with Prostate Cancer

Formula of Yu et al for Predicting Lymph Node Metastases in a Patient with Prostate Cancer (Yale Formula)

Nomogram of Martini et al for Extracapsular Extension of Prostate Cancer

Nomogram of Parker et al for Prediction of Recurrent Prostate Cancer with Extrapelvic Extension

Nomogram of Winter et al for Predicting Sentinel Lymph Node Metastases from a Prostate Cancer

Nomogram of Sayyid et al for Ipsilateral Extraprostatic Extension of Prostate Cancer

Nomogram of Gandaglia et al for Extended Lymph Node Dissection for a Male with Prostate Cancer

Nomogram of Zhu et al for Diagnosis of Prostate Cancer in a Chinese Adult Using p2PSA

Model of Iyama et al for Distinguishing a Transition Zone Prostate Cancer from Benign Prostatic Hyperplasia (BPH)

Nomogram of Martini et al for Predicting Seminal Vesicle Invasion (SVI) in a Patient with Prostate Cancer

Nomogram of Steuber et al for Prediction of Extracapsular Extension for a Male with Prostate Cancer

Score of Dutto et al for Insignificant Prostate Cancer

Model of Cao et al for Predicting Lymph Node Metastases for a Chinese Male with Prostate Cancer

Prognostic Model of Armstrong et al for Predicting Survival of a Chemotherapy Naive Male with Metastatic Castration-Resistant Prostate Cancer

Predictors of Thompson et al for Prostate Cancer

Nomogram of Han and Partin for Clinically Localized Prostate Cancer

Table of Han and Partin for Clinically Localized Prostate Cancer

Table of Makarov et al for Clinically Localized Prostate Cancer

Table of Eifler et al for Clinically Localized Prostate Cancer

Table of Tosoian et al for Clinically Localized Prostate Cancer

1997 Table of Partin et al for Clinically Localized Prostate Cancer

1993 Table of Partin et al for Clinically Localized Prostate Cancer

Prognostic Factors of Lahat et al for a Soft Tissue Sarcoma in an Adult

Manchester Criteria for Neurofibromatosis 2

NIH Criteria for the Diagnosis of Neurofibromatosis Type 2

Criteria of the National Neurofibromatosis Foundation (NNFF) for Neurofibromatosis 2

Diagnostic Criteria for Schwannomatosis

Juvenile Fibrosarcoma (Infantile Fibrosarcoma) of the Eyelid or Orbit

Mucoepidermoid Carcinoma of the Conjunctiva

Tumor Doubling Time (TDT) of a Uveal Melanoma

Algorithm of Wright et al for the Diagnosis of a Lacrimal Gland Tumors

Immunohistochemical Stains for Evaluating Sentinel Lymph Nodes for a Patient with Merkel Cell Carcinoma

Nomogram of Wong et al for Predicting Metastasis to a Sentinel Lymph Node from a Malignant Melanoma

Clinicopathologic Stages of Butchart et al for Diffuse Mesothelioma

Nevoid Basal Cell Carcinoma Syndrome (NBCCS, Gorlin Syndrome, Basal Cell Nevus Syndrome)

Prognostic Factors of Hofmann et al for a Patient Undergoing Pulmonary Metastasectomy from Renal Cell Carcinoma

Clinical Findings Associated with Epidural Metastases with Spinal Cord Compression

Delay of Diagnosis in a Patient with Spinal Cord Compression Due to Metastastic Carcinoma

Peritoneal Surface Disease Severity Score (PSDSS) for Metastatic Colorectal Cancer to the Peritoneum

Colorectal Peritoneal Metastases Prognostic Surgical Score (COMPASS) of Simkens et al

Models of Segelman et al for Metachronous Peritoneal Carcinomatosis Associated with Colorectal Cancer: Model for Colon Cancer

Models of Segelman et al for Metachronous Peritoneal Carcinomatosis Associated with Colorectal Cancer: Model for Rectal Cancer

Volume-Time Index (VTI) in Peritoneal Metastases from a Colorectal Carcinoma

Brain Metastasis Velocity (BMV)

Nomogram of Jakub et al to Predict Upstaging of a Ductal Carcinoma in Situ (DCIS) to Invasive Breast Carcinoma

Nomogram of Briganti et al for Predicting Lymph Node Invasion in a Patient with Prostate Cancer

Naples Prognostic Score (NPS)

Clinical Survival Prediction Model of Arends et al for Hypopharynx Cancer

Nomogram of Zhang et al for Nonmetastatic Nasopharyngeal Carcinoma

Major Salivary Gland Distant Metastases Risk Score of Lukovic et al

Risk Categories of Schulte et al for Parathyroid Carcinoma

TNM Classification of Schulte et al for Parathyroid Carcinoma

Prognostic Factors of Villar-del-Moral et al for a Patient with Parathyroid Carcinoma

Preoperative Score of Xue et al for the Diagnosis of Parathyroid Carcinoma

Risk Scores of Suh et al for Papillary Carcinoma of the Thyroid: RSS1 Score

Risk Scores of Suh et al for Papillary Carcinoma of the Thyroid: RSS2 Score

Clinical Features of Parathyroid Carcinoma

Parathyromatosis

Risk Score of Ng et al for Predicting Survival of a Patient with EGFR-mutant Non-Small Cell Lung Cancer (NSCLC)

VAGAS Score (Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms) of Puhr et al

Models of Zhang et al for Survival in a Patient with Gastric Cancer: All Age Groups

Models of Zhang et al for Survival in a Patient with Gastric Cancer: Older Adult

Nomogram of Wu et al for Predicting Lymphatic Infiltration in Colorectal Cancer

Nomograms of Zhang et al for Colorectal Adenocarcinoma: Cancer-Specific Survival

GAG-HCC Scores of Yuen et al for Hepatocellular Carciinoma in a Patient with Chronic Hepatitis B: Core Promoter Mutation Testing Not Available

CAMD Score for Predicting Hepatocellular Carcinoma (HCC) in a Patient with Chronic Hepatitis B Who Is Receiving Antiviral Therapy

PAGE-B Score of Papatheodoridis et al for Risk of Hepatocellular Carcinoma in a Patient with Chronic Viral Hepatitis B on Antiviral Therapy

HCC Prediction Score of Wong et al for Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B

GAG-HCC Scores of Yuen et al for Hepatocellular Carciinoma in a Patient with Chronic Hepatitis B: Core Promoter Mutation Testing Available

Predictors of Al-Mofleh et al for Malignant Biliary Strictures

Nomogram of Gu et al for a Patient with Renal Cell Carcinoma and a Venous Tumor Thrombus

Risk Factors of Chen et al for Mortality in a Patient with Renal Cell Carcinoma and an Associated Venous Tumor Thrombus

CANLPH Score of Komura et al for a Patient with Renal Cell Carcinoma

Model of Fan et al for Predicting the Risk of Bone Metastases in a Patient with Bladder Cancer

Nomogram of Ouldamer et al for Predicting a Prognosis for a Woman with Endometrial Cancer

Pathologic Findings of Scandura et al Predictive of Metastatic Disease at Presentation in a Male with Testicular Seminoma

Nomograms of Yang et al for Predicting Survival for a Patient with Osteosarcoma: Nomogram A

Nomograms of Yang et al for Predicting Survival for a Patient with Osteosarcoma: Nomogram B

Models of Callegaro et al for a Patient with a Localized Soft Tissue Sarcoma of an Extremity: Overall Survival

Models of Callegaro et al for a Patient with a Localized Soft Tissue Sarcoma of an Extremity: Distant Metastases

Pigmented Basal Cell Carcinoma

Paraneoplastic Syndromes Associated with Mesothelioma

Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS)

Prognostic Score of Katagiri et al for a Patient with Skeletal Metastases

B2 Prognostic Index (B2PI) for Metastatic Breast Cancer

Nomogram of Xiong et al for Survival in a Woman with Metastatic Breast Cancer

Prognostic Index of Puente et al for a Woman with Metastatic Recurrent Breast Cancer

Indications of Sugarbaker for Conservative Therapy When Considering a Debulking Procedure for Peritoneal Carcinomatosis

Score of Nenclares et al for Predicting Overall Survival After Irradiation for Metastatic Spinal Cord Compression

Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Walking Score

Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Eating Score

Functional Palliative Prognostic Index (FPPI) of Hiratsuka et al: Communicating Score

Classification of Lagman et al for Ecchordis Physaliphoris and Chordoma

Predictors of Komura et al for Cancer-Specific Survival for a Patient with Renal Cell Carcinoma

Classification of Residual Tumor (R0, R1, R2)

Nomograms of Fakhry et al for Oropharyngeal Cancer: Overall Survival

Nomograms of Fakhry et al for Oropharyngeal Cancer: Progression-Free Survival

Calcifying Epithelial Odontogenic Tumor (Pindborg Tumor, CEOT)

Grading Scheme of Fuchs et al for Medullary Thyroid Carcinoma

Model of Yu et al for Preoperative Prediction of Follicular Carcinoma in a Thyroid Nodule

Staging Systems of Karadaghy et al for Nonmetastatic Papillary Thyroid Carcinoma: Functional Severity Staging System (FSSS)

Staging Systems of Karadaghy et al for Nonmetastatic Papillary Thyroid Carcinoma: Clinical Severity Staging System (CSSS)

Model of Strand for Predicting 30-Day Mortality Following Resection of a Lung Cancer

Differentiation Between Type A and Type AB Thymomas

Histologic Criteria for Atypical Type A Thymoma

NCCN 2021 Updated Contraindications to Breast Conserving Therapy

Indications for Prophylactic Mastectomy

Findings Suggestive of a Genetic Risk for Breast Cancer: No Personal History of Cancer

Findings Suggestive of a Genetic Risk for Breast Cancer: With a Personal History of Breast Cancer

Gene Mutations Associated with Hereditary/Familial Breast Cancer

Fibrinogen and Albumin (FA) Score for Prognosis of Esophageal Cancer

Model of Chen et al for Predicting Mortality for a Patient with Squamous Cell Carcinoma of the Esophagus

Score of Ahmadi et al for Distinguishing Malignant from Benign Esophageal Disease

CAP/ASCP/ASCO Guideline for HER2 (ERBB2) Testing in Gastroesophageal Adenocarcinoma

Gastric Cancer Peritoneal Carcinomatosis Risk Score of Ji et al

Canton Score of Sun et al for Gastric Cancer

Nomograms of Zhang et al for Colorectal Adenocarcinoma: Overall Survival

Predictive Model of Imperiale et al for Advanced Colorectal Neoplasia in an Asymptomatic Adult

HERACLES Diagnostic Criteria for HER2 (ERBB2) Scoring of a Colorectal Cancer

Asia-Pacific Proximal Colon Neoplasia Risk Score

Model of Dorajoo et al for Survival Following Primary Tumor Resection in Stage IV Colorectal Cancer with Unresectable Metastases

Prognostic Scoring System of Kishiki et al for Incurable Stage IV Colorectal Cancer

Nomogram of Chen et al for Predicting Survival for a Patient with a Gastrointestinal Stromal Tumor (GIST)

Nomogram of Li et al for Predicting Recurrence-Free Survival for a Patient with a Primary Gastrointestinal Stromal Tumor (GIST)

aMAP Score of Fan et al for Predicting Hepatocellular Carcinoma in a Patient with Chronic Hepatitis

PANAMA Score of Hank et al for Predicting Survival After Therapy for Pancreatic Cancer

MD Anderson Cancer Center (MDACC) Clinical Borderline Resectable Classification (CBRC) System for Pancreatic Cancer

Nomogram of Ge et al for Predicting Survival of a Patient with a Metastatic Nonfunctioning Pancreatic Neuroendocrine Carcinoma

Bilateral Renal Cell Carcinoma

Cancer of the Bladder Risk Assessment (COBRA) Score

Prognostic Factors of Ferrari et al for Primary Squamous Cell Carcinoma of the Vulva

Model of Seebacher et al for Predicting Ovarian Cancer in a Patient with an Adnexal Mass

Nomogram of Martini et al for Predicting Extracapsular Extension of Prostate Cancer

Prognostic Factors of Gootee et al for a Patient with a Leiomyoscarcoma

Model of Huq et al for Predicting the Discharge Location for a Hospitalized Patient Treated for a Brain Tumor

Asan Intracranial Meningioma Scoring System (AIMSS) of Lee et al

Grading System of Rutkowski et al for the Consistency of a Pituitary Adenoma

Merkel Cell Polyomavirus and Merkel Cell Carcinoma

Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome

Risk of Sarcoma in a Patient with Hereditary Retinoblastoma

Risk of Epithelial Carcinoma and Melanoma in a Patient with Hereditary Retinoblastoma

Score of Kim et al for Predicting Survival Following Resection of Colorectal Liver Metastasis

Nomogram of Beppu et al for Predicting Disease-Free Survival (DFS) After Resection of Colorectal Liver Metastases

Model of Dai et al for Early Recurrence of Colorectal Liver Metastases

Early Recurrence After Curative Hepatectomy for Liver Metastases from a Colorectal Carcinoma

Prognostic Model of Amano et al Following Resection of Liver Metastases from a Colorectal Carcinoma

Predictors of Nakajima et al for Site of Tumor Recurrence Following Hepatectomy for Metastatic Colorectal Cancer

Prognostic Nomogram of Imai et al for a Patient with Initially Unresectable Colorectal Liver Metastases

Urgent Chemotherapy for a Life-Threatening Complication of a Solid Malignancy

Sekhar Grading System for a Cranial Chordoma (SGSCC)

FA (Fibrinogen and Albumin) Score of Li et al for Skull Base Chordoma

Challenges in the Diagnosis of Chordoma

Clinical and Radiological Features of a Skull Base Chordoma

Hopkins Response Criteria for a Head and Neck Cancer on a FDG-PET/CT Scan

Prognostic Nomogram of Zhuang et al for a Patient an Oral Squamous Cell Carcinoma

iBD Model of Yu et al for a Patient with a Squamous Cell Carcinoma of the Tongue

Prognostic Score of Chen et al for a Patient with Nasopharyngeal Cancer and Bone Metastases

Prognostic Factors of Tian et al for a Patient with Nasopharyngeal Carcinoma and Synchronous Liver Metastasis

Model of Xia et al for Predicting Distant Metastases in a Patient with Nasopharyngeal Carcinoma

Risk Factors of Cao et al for Survival in a Patient with Nasopharyngeal Carcinoma with Bone Metastases

Prognostic Factors of Cao et al for Mortality of a Patient with Lung Metastasis from a Nasopharyngeal Carcinoma

Sonographic Score of Lo et al for Prediction of a Major Salivary Gland Tumor

TALK Score of Sherman et al for Predicting Larynx Preservation in a Patient with Laryngeal Cancer

Model of Fang et al for Predicting Papillary Thyroid Carcinoma Based on Ultrasonographic Features of a Thyroid Nodule

Lung Cancer Prognostic Index of Alexander et al for Predicting Survival After the Diagnosis of Non-Small-Cell Lung Cancer (NSCLC): Full Model (LCPI)

Lung Cancer Prognostic Index of Alexander et al for Predicting Survival After the Diagnosis of Non-Small-Cell Lung Cancer (NSCLC): Modified Model (m-LCPI)

Model of Wang et al for a Patient with a Small Cell Lung Cancer (SCLC)

Nomogram of Tang et al for Predicting Survival of a Patient with a Neuroendocrine Tumor of the Thymus

Nomogram of Zhao et al for Predicting Survival of a Patient with Thymoma

Margin Index for Ductal Carcinoma In Situ (DCIS) of the Breast

Model of D'Journo et al 90-Day Mortality Following Esophagectomy for Cancer

Prognostic Score of Lu et al for a Patient with Gastric Cancer Following Gastrectomy

Clinical Stage Prediction (CSP) Score of Taniguchi et al for Staging Gastric Cancer

Geriatric Risk Score of Souwer et al for an Older Patient with Colorectal Cancer

Endoscopic Score of Kakushima et al for Differentiating Between a Duodenal Adenoma and Adenocarcinoma

Early-Onset (Young-Onset) Colorectal Cancer (EOCRC)

Preoperative Calculator of Gabriel et al for Predicting Survival Following Resection of a Hepatocellular Carcinoma

Prognostic Score of Wang et al for a Patient with Hepatocellular Carcinoma

Nomogram of Hyder et al for Predicting Survival of a Patient with an Intrahepatic Cholangiocarcinoma

Nomogram of Ma et al for Survival After Surgical Resection of a Gallbladder Cancer

Nomogram of Ma et al for Predicting Survival of a Patient with a Left-Sided Pancreatic Adenocarcinoma After Surgical Resection

Prognostic Factors of Akkaya et al for a Woman with Adenocarcinoma of the Fallopian Tube

Score of Pradjatmo et al for Malignancy in a Hydatidiform Mole

HALP and HALPG Scores of Guo et al for Predicting Prognosis for a Patient with Metastatic Prostate Cancer

Updated IGCCCG Prognostic Factors for Metastatic Seminoma

Risk Score Model of Dong et al for Predicting Metastases for a Patient with an Osteosarcoma

Prognostic Model of Cao et al for a Patient with Liposarcoma

Hibernoma

REM (Risk of Endometrial Malignancy) Model of Angioli et al

Clinical Prediction Model of Brims et al for a Patient with Malignant Pleural Mesothelioma

Pathologic Fracture Mortality Index (PFMI) of Raad et al

Risk Model of Anzuategui et al for a Patient Undergoing Spinal Metastasis Surgery

Prognostic AL Score of Shi et al for a Patient with a Malignant Pleural Effusion

Score of Cao et al for Survival Following Palliative Primary Tumor Resection in a Patient with Unresectable Metastatic Colorectal Cancer

Risk Factors of Dunlap et al for Chyle Leak Following Radical Neck Dissection

Prognostic Model for Advanced Cancer (PRO-MAC) of Hum et al

Model of Bourdel-Marchasson et al for Predicting 1-Year Mortality for an Older Adult with Cancer

Glasgow Microenvironment Score (GMS)

BD Score of Almangush et al for a Patient with a Squamous Cell Carcinoma of the Tongue

Model of Dong et al for Predicting Survival for a Patient with a Typical Lung Carcinoid Tumor

Predictors of Rueth et al for Complications Following Surgical Resection in an Older Adult with Non-Small Cell Lung Cancer

Prognostic Models of Miyoshi et al for a Patient with Stage IV Colorectal Cancer After Concurrent Curative Resection: Nomogram for Cancer-Specific Survival (CSS)

Prognostic Models of Miyoshi et al for a Patient with Stage IV Colorectal Cancer After Concurrent Curative Resection: Nomogram for Relapse-Free Survival (RFS)

Model of Weiser et al for Predicting Survival for a Patient with Locally Advanced Rectal Cancer

Neoadjuvant Rectal (NAR) Score Following Preoperative Chemoradiation

Nomogram of Kanemitsu et al for Predicting Overall Survival for a Patient with a Colon Cancer

Classification of Dworak et al for Regression of a Rectal Cancer Following Preoperative Chemoradiation

AGMA Score of Sotiropoulos et al for a Patient Undergoing Liver Transplant for Hepatocellular Carcinoma

Vanderbilt Clinical Score of Das et al for Predicting Progression-Free Survival for a Patient with a Neuroendocrine Tumor Following Lu-177 Dotatate Therapy

2019 World Health Organization (WHO) Classification of Neuroendocrine Neoplasms (NEN) of the Gastrointestinal and Hepatobiliary Organs

Prognostic Factors of Begum et al for Neuroendocrine Carcinoma with Unknown Primary (CUP)

Virilizing Adrenocortical Carcinoma in a Pediatric Patient

O-RADS MRI Classification for an Adnexal Mass

Hedienreich Criteria for Retroperitoneal Lymph Node Dissection for Post-Chemotherapy Residual Masses in a Patient with Nonseminomatous Germ Cell Tumor of the Testis

Prognostic Model of Zhou et al for a Patient with Ewing Sarcoma of Bone

Classification of Trouillas et al for Pituitary Adenomas

Algorithm of Guaraldi et al for Evaluating a Patient with a Pituitary Neuroendocrine Tumor (Adenoma)

Dermatofibrosarcoma Protuberans (DFSP) Associated with Severe Combined Immunodeficiency (SCID)

PTEN Hamartoma Tumor Syndrome (PHTS)

Models of Tseng et al for a Patient with Disseminated Malignancy Undergoing Surgical Intervention: Model for 30-Day Morbidity

Models of Tseng et al for a Patient with Disseminated Malignancy Undergoing Surgical Intervention: Model for 30-Day Mortality

Magnetic Resonance Grading Scheme of Tian et al for Skull Base Chordoma (SBC)

Nomogram of Zou et al for Predicting Survival of a Patient with a Spinal Chordoma

PADUA (Preoperative Aspects and Dimensions Used for an Anatomical) Score of Ficarra et al for a Renal Tumor

Serum Lactate Dehydrogenase (LDH) to Absolute Lymphocyte Count Ratio

PILE Score in a Patient Treated with Anti-PD-1 or Anti-PD-L1 Inhibitors

Prediction Score of Said et al for Oral Cavity Cancer

Prognostic Score of Lupato et al for Recurrent Squamous Cell Carcinoma of the Head and Neck

International Medullary Thyroid Carcinoma Grading System (IMTCGS)

VA Lung Cancer Mortality (VALCAN-M) Score of Heiden et al

Prognostic Scores of del Arco et al for a Patient with Resected Gastric Cancer

Risk Factors of Park et al for Recurrence and Death Following Complete Surgical Resection of Stage I Gastric Cancer

Primary Tumor Score (PTS) and Other Prognostic Markers of Haraguchi et al for Resectable Gastric Cancer

Prognostic Score of Qian et al for a Patient with Resectable Gastric Cancer

Score of Sekiguchi et al for Predicting Lymph Node Metastases in Early Gastric Cancer

Prognostic Factors of Shiraishi et al for a Patient with a Large Gastric Cancer

Aspartate Aminotransferase (AST) to Lymphocyte Ratio Index (ALRI) for Predicting Survival in Patients with Hepatocellular Carcinoma

Six and Twelve Prognostic Model of Wang et al for Transarterial Chemoembolization (TACE) of an Hepatocellular Carcinoma (HCC)

Platelet-Albumin-Bilirubin (PALBI) Prognostic Score for Hepatocellular Carcinoma

Platelet-Albumin (PAL) Prognostic Score of Shindoh et al for Hepatocellular Carcinoma

EZ-ALBI (Albumin-Bilirubin) Prognostic Score for Hepatocellular Carcinoma

Prognostic Factors of Ho et al for a Patient with Hepatocellular Carcinoma

Singapore Liver Cancer Recurrence (SLICER) Score of Ang et al

Histologic Tumor Regression Grading (HRTG) Score of Chatterjee et al for Pancreatic Adenocarcinoma

Pancreatic Head Tumor (PHT) Score of Muttillo et al

Risk Factors of Armstrong et al for Progression of an Intraductal Papillary Mucinous Neoplasm (IPMN)

Model of Bereza-Carlson et al for Early Mortality Following Surgery for Pancreatic Cancer (SPEM)

Zonal NePhRO Score of Hakky et al for Renal Tumor Complexity Classification

Zero Ischemia Index (ZII) of Li et al for a Patient Undergoing Partial Nephrectomy for a Renal Tumor

Zhongshan Score (ZS) of Zhou et al for a Patient with a Renal Tumor

Renal Tumor Invasion Index (RTII)

Surgical Approach Renal Ranking (SARR) for a Patient with a Renal Tumor

Simplified PADUA Renal (SPARE) Nephrometry Score for a Patient with a Partial Nephrectomy

Centrality Index (C Index) for a Renal Tumor

Renal Tumor Contact Surface Area (CSA)

Diameter-Axial-Polar (DAP) Nephrometry

Nomogram of Sheng et al for Predicting a High-Grade Cervical Lesion

Algorithm of Vang and Shih for the Diagnosis of Serous Tubal Intra-Epithelial Neoplasia

Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Inflammatory-Nutrition Score (INS)

Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Nomogram Using the Inflammatory-Nutrition Score (INS)

Models of Xu et al for a Patient with R0 Resected Head and Neck Soft Tissue Sarcoma: Nomogram Without the Inflammatory-Nutrition Score (INS)

Prognostic Score of Villard et al for Survival of a Patient with Colorectal Liver Metastases

Model of Owusuaa et al for Predicting 1-Year Mortality for a Patient with Advanced Cancer

Laboratory Prognostic Score (GI-LPS) of Nagai et al for a Terminally Ill Patient with Gastrointestinal Malignancy

Predictors of Christ et al for 72-Hour Mortality for a Patient Admitted to an Acute Palliative Care Unit

Anti-NMDA Receptor (NMDAR) Autoimmune Encephalitis Associated with an Ovarian Teratoma

Risk Models of Rampoldi et al for Surgical Mortality in Acute Type A Aortic Dissection (International Registry of Acute Aortic Dissection Score, IRAADS): Preoperative Model

Nomograms of Wang et al for a Patient with Buccal Cancer: Nomogram for Overall Survival

Nomograms of Wang et al for a Patient with Buccal Cancer: Nomogram for Cancer Specific Survival

Nomogram of Zhou et al for Predicting Survival for a Patient with an Oral Squamous Cell Carcinoma

Nomogram of Lu et al for Predicting Lymph Node Metastasis for a Patient with Papillary Thyroid Carcinoma

Score of Lee et al for Predicting 2-Year Survival in a Patient with a Stage I to III Non-Small Cell Carcinoma of the Lung (NSCLC)

SABCIP Score of Tahara et al for Predicting In-Hospital Death After Lung Cancer Surgery

Immune-Based Prognostic Risk Score (IMPRS) of He et al for Non-Small Cell Lung Cancer (NSCLC): Nomogram A

Immune-Based Prognostic Risk Score (IMPRS) of He et al for Non-Small Cell Lung Cancer (NSCLC): Nomogram B

Nomogram of Guo et al for Selecting a High-Risk Patient in China for CT Lung Screening

VIOLA Score of Puhr et al for a Patient with Esophagogastric Adenocarcinoma

Score of Chang et al for Prognosis in a Patient with Esophageal Cancer Treated with Immune Checkpoint Inhibitor

Model of Pan et al for Predicting Serosal Invasion By a Gastric Cancer

Nomogram of Valentini et al for Predicting 5-Year Mortality for a Patient with Locally Advanced Rectal Cancer

Prognostic Factors of Wu et al for Gastrointestinal Stromal Tumors (GIST)

Nomogram of Chen for Predicting Survival in a Patient with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization

CRAFITY Score of Scheiner et al for Evaluating a Patient with Hepatocellular Carcinoma for Immunotherapy

Nomogram of Zhang et al for Predicting the Risk of Cancer in a Gallbladder Polyp

Nomogram of Jiang et al for Predicting Malignancy in a Pancreatic Cystic Neoplasm

WHO Reporting System for Pancreaticobiliary Cytopathology

Prognostic Index of Huang et al for a Patient with Pancreatic Cancer

CRP-Bellmunt Score of Abuhelwa et al for Urothelial Carcinoma Treated with Immunotherapy

Vesical Imaging Reporting and Data System (VI-RADS) Score for the Urinary Bladder

Nomogram of Wang et al for Predicting Lymphovascular Space Invasion (LVSI) in a Patient with Endometrial Cancer

Copenhagen Index (CPH-I) for Ovarian Cancer

Prognosis Predictive Score Around Primary Debulking Surgery (PPSP) of Kawahara et al for a Woman with Ovarian Cancer

Risk Scores of Salas et al for a Patient with a Solitary Fibrous Tumor

Risk Score of Georgiesh et al (G-Score) for a Solitary Fibrous Tumor

Revised Score of Demicco et al for Predicting Risk of Metastases in a Patient with Solitary Fibrous Tumor

Risk Score of Thompson et al for an Orbital Solitary Fibrous Tumor

Risk Score of Pasquali et al for a Patient with an Extra-Pleural and Extra-Meningeal Solitary Fibrous Tumor (SFT)

Risk Factors of Segal et al for an Unacceptable Delay in the Diagnosis of a Primary Intradural Spinal Cord Tumor

Immune-Related Risk Score of Ren et al for Predicting Survival for a Patient with Glioblastoma

Malignant Pleural Effusion (MPE) Score of Chantharakhit and Sujaritvanichpong

Clinical Risk Scores of Brudvik et al for Predicting Survival After Resection of Colorectal Cancer Liver Metastases

Predictors of Frosch et al for a Delay in the Start of Cancer Therapy

Cancer Survival Index (CSI) of Gaiger et al

Metastatic Uveal Melanoma Prognostic Score (MUMPS) of Kelly et al

Predictors of Neck Dissection Failure in a Patient with an Oropharyngeal Squamous Cell Carcinoma

Tumor Burden Scale (TBS)

HALP Score of Guo et al

Nomogram of Chen et al for Predicting Overall Survival for a Patient with Locally Advanced Hypopharyngeal Cancer

MOSS Score of Woo et al for Predicting High Grade Histology for a Stage I Lung Adenocarcinoma

Predictive Score of Honda et al for Respiratory Complications in a Child with a Mediastinal Tumor

Prognostic Model of Lin et al for a Woman with Breast Cancer

Model of Kubo et al for Predicting Peritoneal Seeding in Advanced Gastric Cancer

MPK Immunohistochemical Score of Liu et al for Gastric Cancer

Nomogram of Liu et al for Predicting Survival of a Patient with Appendiceal Cancer

Nomogram of Constantin et al for Predicting Overall Survival Following Emergency Surgery for Colorectal Cancer

Nomogram of Song et al for Predicting the Malignant Potential of a Gastrointestinal Stromal Tumor (GIST)

R3-AFP Score of Costentin et al for Predicting Recurrent Hepatocellular Carcinoma After Liver Transplantation

Modified ALBI (mALBI) Grade of Hiraoka et al

MICAN Criteria of Hiraoka et al for Hepatocellular Carcinoma

ALBI-TNM (ALBI-T) Score of Hiraoka et al

CITRUS-MICAN Score of Hiraoka et al for Identifying a Patient with Hepatocellular Carcinoma for Whom TACE Is Unsuitable

Tumor Marker (TM) Score of Hiraoka et al for a Patient with Hepatocellular Carcinoma

Up-to-Eleven Criteria of Kim et al for a Patient with Intermediate Stage Hepatocellular Carcinoma

MAPS-CRAFITY Score for Hepatocellular Carcinoma

GRAPHS-CRAFITY Score for Hepatocellular Carcinoma

Prognostic Model of Mo et al for Unresectable Hepatocellular Carciinoma Treated with PD-1 and Angiogenesis Blockade (LANS Score)

Nomogram of Han et al for Predicting Malignancy in a Gallbladder Polyp

Model of Yang at al for Predicting Cancer in a Gallbladder Polyp (Korean Model)

Model of Belkouz et al for Predicting Survival in a Patient with Distal Cholangiocarcinoma

AACC Prognostic Score of Min-Oo et al for a Patient with Cholangiocarcinoma

CCDC25 Expression in Cholangiocarcinoma

Risk Stratification Model of Chapel et al for a Woman with a Stage I Uterine Leiomyosarcoma (Brigham Risk Model)

Prognostic Score of Trifanescu et al for a Woman with Ovarian Adenocarcinoma

Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) of Kawahara et al for a Woman with an Epithelial Ovarian Cancer

SAVE Testis-sparing Score of Liu et al for a Testicular Tumor: Available Testicular Tissue Volume

SAVE Testis-sparing Score of Liu et al for a Testicular Tumor: Score Determination

Model of Parasiliti-Caprino et al Predicting the Risk of Recurrence After Radical Surgery for Pheochromocytoma

Nomogram of Wu et al for Predicting Survival for a Child with a High-Risk Neuroblastoma

RENEG Score of Trong et al for a Non-Enhancing Glioma

Prognostic Nomogram of Fang et al for a Pediatric Patient with a Medulloblastoma

Model of Li et al for Predicting Peritoneal Carcinomatosis for a Patient with Gastric Cancer

NPD Score of Ye et al for Evaluating a Patient with Peritoneal Metastasis from Gastric Cancer

Clinical Prediction Score of Chayangsu et al for Response to Chemotherapy in a Patient with Advanced Non-Small Cell Lung Cancer (NSCLC)

Predictive Model of Endo et al for the Use of Adjuvant Chemotherapy in a Patient with Intrahepatic Cholangiocarcinoma

Meta-Lung Score of Ziranu et al for Surgical Resection of Metastatic Colorectal Cancer Limited to the Lungs

Peritoneal Regression Grading Score (PRGS)

Prognostic Factors of Ferraz-Goncalves et al for a Cancer Patient Receiving Palliative Care

Nomogram of Owusuaa et al for 1-Year Mortality in a Patient with Advanced Cancer

Oncology: Non-Hematologic